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In order to provide improved and more personalized medical care, better diagnosis and 
quantification of different biomarkers is necessary.  During the tenure of my PhD I 
have created new systems for biodetection that exist at the interface of light and fluids, 
and that improve the sensitivity, scope, or some other aspect of the device. My first 
major research thrust was in the field of on-chip photonic resonators, where I 
increased the interaction between bioanalytes and light, enabling devices that were 
able to transduce up to a 40% increase in signal for a given amount of analyte.  In my 
second work, I took an existing colorimetric gold nanoparticle reaction, multiplexed it 
for two targets using similar silver structures, and applied it to the differential 
diagnosis of Kaposi’s sarcoma and Bacillary angiomatosis. My results indicate that the 
system created, without any optimization could detect DNA down to nanomolar 
levels, sufficient for use in the field. In my third, and penultimate piece of work, I 
created a smartphone based biosensor capable of quantifying the color change of my 
previous reaction, and extendable to many other systems, including colorimetric 
ELISAs. This sensor system is capable of detecting DNA from Kaposi’s sarcoma 
associated herpesvirus, determining how much is present and uploading results to a 
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central server for later analysis.  Taken together, over the course of my work I have 
created more sensitive and more multiplexed biosensors and shown how they can be 
connected to a smartphone for additional functionality. 
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CHAPTER 1 
 
1. Introduction 
 
1.1 Past, Present, and Future Medical Diagnosis 
 
For many people the scariest moments of their lives will be learning of health 
complications in themselves and their loved ones.  Spending most of their lives being 
generally healthy, patients show up at the doctor with only minor symptoms, and 
begin the process of uncovering what is wrong.  Often times this process begins with a 
familiar physical examination, and ends with a simple prescription of antibiotics, or an 
order to rest for a few days.  Other times, this diagnostic routine goes further, as more 
information is needed, and newer and more sensitive measures are ordered. 
The earliest written records of medical diagnosis date back over four thousand 
years ago to the Egyptians and Greeks [1], though most of what is known today can be 
attributed to scientific developments of the last century.  In these last hundred years or 
so, doctors began applying scientific and statistical methods in large scales to the 
study of the disease (i.e. the first double blind study in 1943 [2]), have categorically 
classified all different types of abnormalities[3] , and have developed treatments and 
therapeutics for many of the worst diseases facing human development [4]. New tools 
have been developed enabling doctors to detect rarer molecules and cells at increasing 
sensitivities, to see inside patients in a dozen different ways, and to detect subtleties 
that have often only just been discovered.   
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Importantly, many of the advances of the last century were made building off of 
similar breakthroughs in fields like electronics, chemistry, and physics.  These new 
tools, treatments and ideas have been unarguably successful, increasing the average 
person’s life expectancy by decades, and helping improve their quality of life 
significantly. They’ve taken advantage of our greatly increased scientific knowledge, 
and allowed us to save and improves lives in ways we couldn’t have imagined a 
century before.  They’ve also mirrored the dynamics of the time, favoring large 
centralized hubs to take advantage of economies of scale, and centralizing much of our 
medical expertise.   
Overall, the state of advanced medical diagnosis today is not fundamentally 
different from the state of computation at the beginning of our information age.  The 
vast amount of our capability is confined to central locations, and largely utilized only 
by professionals in the field.  Only through these gatekeepers can an average person 
learn more about their health status. Just like with computers, having these centralized 
facilities is a significant improvement over not having them, but even greater 
advantages can be realized as some of these diagnostics are distributed to the ultimate 
end user, patients. 
By decentralizing at least the first level of diagnostic tests, simple blood, urine, 
and saliva tests, and things which can be done by physical examination, it could be 
possible to provide better healthcare at less cost.  Some examples already exist, 
including home pregnancy tests and home HIV tests. With over 4 million births a year 
and total revenues of over $220M, it’s easy to imagine the impact of home pregnancy 
tests on medical care [5]. Home HIV saliva tests, just approved in May 2013, will 
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hopefully have a similar effect.  Glucose monitors used by diabetes go a step further, 
not only reducing the cost of providing care, but enabling many diabetics to live 
otherwise normal lives, a reality that would be difficult without such technologies.  In 
addition to these technologies, home health monitoring exists for cholesterol, urine 
tests, and a number of other applications, all with some level of success. 
Together, these two devices, home pregnancy tests and glucose monitors, also 
illustrate a key difference between two types of medical diagnostics: qualitatively read 
binary tests and quantitative tests which require additional hardware.  While tests 
strips such as pregnancy tests have seen some success reaching home markets, 
quantitative tests have had a much harder time finding widespread adoption, with 
glucose tests being the exception, rather than the rule. Mainly this problem is caused 
by the cost of the hardware required to read out tests, and the infrequency which 
medical tests are required by generally healthy people.  Making an analogy to the well 
known razor-razorblade business model in which razors are sold cheap to drive the 
sales of blades, for individual health problems often the cost of the “razor” can’t be 
amortized over enough “blades.” 
This problem can be solved by creating a platform that combines many different 
health tests and only a single reader. A single diagnostic platform that ultimately 
connects many tests could provide an unprecedented ability to monitor patient’s health 
in real time, explain the results in a meaningful way to the patient, communicate 
results to the doctor, and provide better care at both the patient and population level.  
Importantly, such a device would ultimately share many characteristics with one of the 
most important technologies of this decade, the smartphone. 
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1.2 The Smartphone Revolution 
 
It’s extraordinary when a single technology comes along which changes the way 
people all over the developed world go about their daily lives. Almost 46% of 
American adults have a smartphone today and by 2016 an anticipated 250 million 
smartphones will be in use US[6].  Smartphones are used to obtain information and for 
entertainment, financial transactions, photography, exercise, and most recently and 
relevantly, for healthcare. 
 Already, commercial healthcare applications exist including well known include 
exercise and fitness monitoring applications [7-9], as well as vaccine logs [10], sleep 
monitoring applications [11], diagnosis decision support apps [12], and applications 
that can be used to image and diagnose skin cancer [13]. Additionally, smartphones 
accessories exist that can collect heart rate [14], blood pressure [15], and blood oxygen 
saturation [16]. Together, the total smartphone based healthcare was worth $1.3 billion 
in 2011, up nearly twice its 2010 value, and is expected to continue growing rapidly 
[17].  
Importantly however, all these existing commercial smartphone based systems rely 
on user input or physical measurements (e.g. blood pressure, heart rate) that are 
generally non-specific vital signs and were simply commercialized first because they 
are easy to obtain.  What remains to be done is quantitative monitoring of different 
pathogens and antigens in bodily fluids such as sweat, saliva, urine, and blood, all of 
which contain a tremendous amount of health information.  As explained in 1.1, these 
quantitative signals are often the most difficult to measure at home, and so far, have 
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been only marginally successful.  Obtaining numerical health information like this, 
such as cholesterol and vitamin levels, has been one aim in our broader body of work. 
Looking elsewhere, if the development of the smartphone has caused extraordinary 
change in the developed world, its introduction into developing nations has been 
nothing short of profound. While personal computers proved too expensive to reach 
some locations, cell phones are thriving in locations where electricity is often periodic, 
and serving as the primary means of internet access in these locations.  In areas such 
as India and Africa, cell phones have already revolutionized how people contact each 
other, share information, and even pay for things.  In 2011, over 60% of Africans, or 
600 million customers, had access to cell phones, with predictions expecting over 80% 
penetration by 2014 [18].  Smartphone penetration is picking up at an incredible rate, 
with approximately 100M connections in 2013, and predictions of over 230M 
connections in 2015. 
Importantly, in these locations smartphones have reached places where developed 
world healthcare haven’t.  Not only can smartphones act as a gatekeeper for further 
healthcare, in these locations, smartphone based diagnostics can help provide a level 
of care that wasn’t previously possible.  By connecting new diagnostic tests to the 
communications capabilities of smartphones, more advanced technologies can be 
deployed, and doctor’s opinions can even be brought in to make life saving decision in 
locations too remote for hospital care. 
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1.3 Kaposi’s sarcoma, an infectious disease and a lens for diagnostic development 
 
One condition where better diagnostics are drastically needed is in the case of 
Kaposi’s sarcoma (KS) in sub-Saharan Africa.  Perhaps KS is best known in the 
developed world for its relationship with the onset of the acquired immunodeficiency 
syndrome (AIDS) epidemic in the early 1980s. As patients presented at the hospital 
with AIDS, often their first symptom was the presence of red skin lesions, a symptom 
not of AIDS, but actually of KS, an opportunistic disease [19-22]. During the 
following years, significant research efforts were made to determine the cause of 
AIDS, leading to the discovery of HIV in 1983 [23-24]. A little over ten years later the 
cause of KS was first connected to a second virus, Kaposi’s sarcoma-associated 
herpesvirus (KSHV), later given the alternative designation of human herpesvirus 8 
(HHV-8) [25]. 
KS is the most prevalent cancer faced by HIV-infected individuals not on therapy. 
Initial studies showed that it affected 1 in 20 HIV-positive patients [26]. Highly active 
anti-retroviral therapy (HAART) has improved the outlook for patients in the 
developed world, but even here it remains increased in incidence as compared to the 
pre-AIDS era [27-28]. In Sub-Saharan Africa, both HIV and KS are endemic, and KS 
is the fourth leading cancer in the region [29]. In Uganda, KS is the number one cause 
of cancer in men [29-30]. 
In some locations KSHV rapidly spreads, presumably through saliva [31-33], and, 
reaches seroprevalence of over half the population [29, 34]. KSHV, similar to the 
better known herpesviruses HSV-1 and HSV-2 (oral and genital herpes) can establish 
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a latent infection, and remains without causing any disease for the remaining life in 
most infected hosts, being necessary but not sufficient of KS development (the other 
condition required being a weakened immune system). In locations where the 
seroprevalence of KSHV is high, the clinically relevant test becomes determining if 
KSHV is present in a specific tumor, and not simply if it is present in a person’s 
blood. Further, this requirement can lead to determining if a significantly high enough 
concentration of KSHV is present, as even seroprevalent virus can cause a PCR to 
come back positive from blood in the biopsy sample. 
In addition to the requirement for sensitive quantitative detection, an additional 
challenge presents itself in the diagnosis of KS in the form of similarly presenting 
diseases.  KS shares a similar presentation and many other histological features with a 
number of diseases including bacillary angiomatosis (BA) caused by Bartonella 
henselae or quintana, and pyogenic granuloma. Taken together, these two challenges 
require any diagnostic for KS to be both sufficiently sensitive and resolved enough to 
separate seroprevelance from actual infection, and to separate KS from other 
infectious conditions. 
In hospitals, these problems are solved and KS diagnostic often takes the form of 
skin biopsies processed for histology using instruments like tissue processing systems 
and microtomes, and stains including not only H&E but also more advanced 
immunohistochemistry specific for unique KSHV proteins. In cases where a diagnosis 
still isn’t certain, polymerase chain reaction (PCR) specific for unique KSHV DNA 
sequences can also be used to confirm a diagnosis. However, these techniques often 
aren’t available in the developing world, and certainly aren’t available or translatable 
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to point of care setting. 
While a point of care diagnostic for KS could revolutionize care in sub-Saharan 
Africa, these two challenges present themselves in the creation of point-of-care 
diagnostics. Additionally, all of the hardware necessary to process a biopsy samples 
must in some way be built into a diagnostic test. 
 
1.4 Point of Care Biosensors in the Literature 
 
Already, a tremendous amount of work has been done on developing point of care 
biosensors.  Devices have been constructed using mechanical [35-36], electrical [37], 
and optical [38] techniques to detect bioanalytes in minute quantities.   Often these 
devices combine microfluidics and other nanotechnologies in order to create tools 
which both operate at the length scale of the detection target and at a macroscopic 
scale which can be simply read-out. Some examples have also been applied in 
developing world settings, where the additional constraints of a lack of resources and 
trained personnel complicate matters [39-40].  
One interesting example is that of on-chip optical resonators.  Optical devices are 
particularly interesting due to their high sensitivity, their capacity for multiplexed 
detections, and their ability to operate interface well with bioanalytes in an aqueous 
solution[41-46]. In the literature, many different optically resonant architectures have 
been studied including photonic crystals [38, 47], microtoroids [48], and 
microring/microracetracks [49-50]. In chapter 1 we construct an optically resonant 
microring, and demonstrate how improvements can be made by increasing bioanalyte-
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core waveguide energy interactions. 
Another interesting example which is investigated more in Chapter 3 is that of 
biosensors which link a biodetection reaction to a colorimetric nanoparticle 
aggregation reaction [51-53].  These reactions are particularly interesting because of 
the simplicity with which they can be read out.  Compared to the previously 
mentioned class of waveguiding biosensors, these devices require significantly 
reduced external equipment, yet exploit similar resonant techniques to achieve high 
sensitivities [51, 54-55]  Some works have even shown detection of unamplified DNA 
[53].  In Chapter 4 we develop our own multiplexed version of such a system, 
traditionally something which has proved challenging to accomplish. 
 A third class of biosensor, only very recently making their introduction in the last 
decade, is that which connects a bioanalyte detection reaction to something that can be 
read out in a smartphone. These tests are particularly useful because of the ubiquity 
with which smartphones not only exist in our lives, but with which people are familiar 
using them. By connecting a complex diagnostic test to an easy to use smartphone, 
systems can often be created that allow nontechnical audiences to complete difficult 
tasks. 
 Some of the earliest examples of these devices have come out of the Ozcan 
research group, where researchers developed field portable microscopes based on 
camera phones [56-59].  Additional works have connected colorimetric test strip 
reactions to smartphones to enable reading out things like pH[60], urine tests [61], and 
cholesterol tests[62].  However, most of these early works use the smartphones 
camera, as opposed to a separate optical detector.  While this has advantages in terms 
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of simplicity, because a medical device manufacturer has no control over the camera 
in a phone, or how to tell if it’s damaged over its lifetime, it provides difficulty in 
producing repeatable measurements.  In Chapter 4 we develop a system which 
attempts to solve this problem. 
 
2. Research Overview and Dissertation Breakdown 
 
In Chapter 2 of this dissertation, a look is taken at the creation of a more traditional 
optofluidics biosensor, based on waveguides and optical ring resonators.  The novel 
device discussed in this chapter is made of polymer, rare for these devices, and is 
constructed in such a way that it is porous, one of the first of its kind.  The additional 
porosity in the device creates more interaction between bioanalytes in the surrounding 
liquid cladding and the optical energy stored in the polymer waveguide.  More 
uniquely, the structure allows the bioanalytes to directly enter the waveguide, and 
interact with the optical energy where it is most concentrated.  Together, these effects 
allow for a biosensor which is 40% more sensitive to changes in the refractive index of 
the cladding solution than a polymer device alone. These improvements to sensitivity 
are significant, and due to the method of fabrication and materials used, devices such 
as the ones in this work could one day potentially see use in a number of different 
medical sensors. 
 In Chapter 3, a first look is taken at creating a diagnostic for KSHV in the 
developing world.  In this work, a novel system of nanoparticles is created capable of 
making the differential diagnosis of KSHV and BA using two different colorimetric 
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reactions.  The system builds on other nanoparticle work for a single target, and shows 
how a colorimetrically multiplexed system can be created.  By monitoring multiple 
color changes, more information can be determined from a single sample collection. 
 In Chapter 4, a smartphone platform capable of reading out the colorimetric test 
from Chapter 2 is developed.  The accessory plugs into the µUSB port of an Android 
smartphone, and uses the power, communications, and connectivity of the phone to 
create a novel biosensor platform.  In this chapter we detail the creation of the device, 
and show how samples of KSHV DNA can be detected in microfluidic chips.  Further, 
we characterize the resolution and sensitivity of the device. 
 Lastly, in chapter 5, I review the accomplishments in this work and provide 
perspective for where the future of the work could go.  I hope that over the course of 
this work a clear change can be seen in how biosensors advance from complicated 
laboratory devices to simple smartphone accessories, completing the same tasks with 
similar sensitivity. It’s my hope that in the future many medical diagnostics will share 
this same transition, and enable people to cheaply and easily run to the pharmacy and 
purchase tests providing a wealth of physiologic information. 
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CHAPTER 2 
 
NANOPOROUS POLYMER RING RESONATORS FOR BIOSENSING 
 
Optically resonant devices are promising as label-free biomolecular sensors due to their ability to 
concentrate electromagnetic energy into small mode volumes and their capacity for multiplexed 
detection. A fundamental limitation of current optical biosensor technology is that the 
biomolecular interactions are limited to the surface of the resonant device, while the highest 
intensity of electromagnetic energy is trapped within the core. In this paper, we present 
nanoporous polymer optofluidic devices consisting of ring resonators coupled to bus 
waveguides. We report a 40% increase in polymer device sensitivity attributed to the addition of 
core energy- bioanalyte interactions. 
 
 
 
 
 
 
 
 
 
 
 
 
Mancuso, M., Goddard, J., Erickson, D. “Nanoporous Polymer Ring Resonators for Biosensing” Optics Express 20, 
1, 245-255 (2012).  Reproduced with permission of the Optics Society of America 
19 
 
1. Introduction 
  
Label-free biosensors are a promising class of biomolecular detectors because they bypass the 
need for a fluorescent, radio, or enzymatic label. Dependence on such a label to detect a 
biomolecular interaction can adversely impact device performance, either by interfering with the 
binding event (false negative) or by non-specific adsorption of the labeling molecule (false 
positive) [1]. There are a number of well developed techniques that permit direct label-free 
detection of bound target biomolecules [2], including optical [3-5], electrical [6], and acoustic 
sensors [7]. Within the broader class of label-free biosensors, optically resonant devices are 
particularly promising due to their ability to concentrate electromagnetic energy into small mode 
volumes, their capacity for multiplexed detections, and their ability to operate in aqueous 
environments [8-13]. A number of different architectures have been investigated in the 
development of optically resonant biosensors, including photonic crystals [5, 14], microtoroids 
[15], and microring/microracetracks [16-17].  
A fundamental limitation to the sensitivity of most optical biosensors is that the biomolecular 
interactions are limited to the surface of the resonant device, while the highest intensity of 
electromagnetic energy is trapped within the core (Fig 1a). An example of a technique that 
attempts to resolve this problem are liquid core slot waveguide biosensors, which confine both 
the target bioanalyte and optical energy to the same volume [18]. These types of devices can also 
be fabricated into ring resonators to further localize optical energy [19], yet their 
commercialization is often hindered by expensive and complicated fabrication. 
At the other end of the spectrum, polymer optical biosensors offer low cost, simple 
fabrication, but suffer from lower sensitivities than silicon equivalents [10, 12-13, 20-22].  
Polymers are commercially available with a range of thermal, mechanical, and optical properties, 
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and can be readily functionalized for the immobilization of biomolecular sensing agents [23]. 
Further, Polymer chemistry can be tuned to yield unique optical structures and properties that are 
difficult to fabricate with traditional silicon based techniques. Due to their cheap material and 
fabrication requirements polymer biosensors lend themselves well to being manufactured as one-
use disposables. Because of this, problems with surface fouling due to repeated use can often be 
mitigated.  
 
 
 
Fig. 1 (a) Traditional on chip optical biosensors rely on biomolecules interacting with a 
traveling waves evanescent field instead of the much higher core energy. (b) When biomolecules 
are present, the optical path length increases and the resonance of a ring resonator red shifts. 
(c) Here we demonstrate polymer devices where biomolecules more strongly interact with the 
core electromagnetic energy by directly entering pores in the resonator. Because of increased 
interaction with the electromagnetic energy, the resonance peak shifts further (Δn2 > Δn1).  
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In this paper, we present a method of increasing the sensitivity of optically resonant polymer 
biosensors. Ring resonators are chosen for their relatively high Q factors and excellent ability to 
localize optical energy. By creating porous resonators, bioanalytes in the detection medium are 
enabled to interact with the core waveguide energy increasing the effect these molecules have on 
the devices resonance, and thus increasing the devices sensitivity, as illustrated in Figure 1. The 
increase in sensitivity associated with added porosity stems from both an increase in the amount 
of bioanalyte allowed to interact with the modal energy as well as an increase in the average 
modal energy the bioanalytes can interact with. Together these effects allow for greater 
enhancements to sensitivity than a similar increase in surface area would if unaccompanied by 
the deeper access pores provide. 
Figure 2 shows an example of a nanoporous polymer optofluidic device consisting of a ring 
resonator coupled to a bus waveguide. These devices are fabricated using imprint lithography, a 
unique blend of polymers, and a selective solvent. By using nanoporous materials, we are able to 
detect biomolecular interactions occurring throughout the core of the ring resonator, enabling a 
40% increase in sensitivity. We demonstrate this technique using polystyrene nanoporous 
waveguides, which we combine with polymeric microfluidics to yield an optofluidic biosensor 
constructed of inexpensive polymers. 
 
2. Methods 
 
Figure 3 shows a schematic representation of the fabrication process. As detailed below, an 
imprint master was prepared using traditional photolithography and coated with an antistiction 
layer before embossing. Selected solvation was used to remove one polymer from a two-polymer 
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system, and microfluidic channels were attached to the resonators to allow localization of target 
biomolecules. Optical excitation studies were then performed to determine changes in the 
resonance and sensitivity of devices as a function of added porosity. 
 
2.1 Mode calculations and simulations 
 
Lumerical FDTD software (Lumerical Solutions, Inc, Vancouver, British Columbia, Canada) 
was used to analyze mode profiles and ring resonators in order to determine the effective 
refractive indices of our waveguides as well as approximate resonator characteristics. Three 
dimensional calculations of mode profiles produced effective refractive indices for our 
waveguides which were then used to determine optimal waveguide cross-sections as well as 
approximate ring radii and coupling lengths.  
 
 
Fig. 2. (a) An illustration of porous waveguides and a ring resonator show the underlying device 
structure. A ring resonator was chosen in order to increase sensitivity by further localizing light 
to a porous location. (b) A scanning electron micrograph (SEM) of two adjacent porous 
waveguides highlights how interactions can occur both around and in the waveguide core.  
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Fig. 3. A two step lithographic process was employed to create nanoporous waveguides. (a) 
First, an embossing master was created out of silicon oxide using standard photolithographic 
techniques and fluorine based etching. (b) Second, a custom polymer resist was spun onto a 
silicon oxide on silicon wafer, imprinted using the embossing master, and then developed using a 
select solvent. 
 
2.2 Silicon master preparation  
 
Hot embossing masters were fabricated from silicon wafers. A 2 µm film of undoped silicon 
oxide was deposited onto clean silicon wafers using plasma enhanced chemical vapor deposition. 
Wafers were then treated with P10 primer for ten seconds to promote photoresist adhesion, after 
which SPR 955 - 0.9 (MicroChem Corporation, Newton, MA, USA) positive photoresist was 
spun at 3000 rpm for 30 seconds. After a 90 second soft bake at 90 oC, wafers were patterned on 
an i-line autostepper, subjected to a post exposure bake of 90 seconds at 115 oC, and developed 
for one minute in AZ300-MIF alkaline developer. Patterned wafers were anisotropically etched 
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on an Oxford PlasmaLab 80+ using fluorine based gas chemistry (50 sccm CHF3, 2 sccm O2, 50 
mTorr, 200 W) to yield 1.1 µm deep features. After stripping residual photoresist, etched masters 
were cleaned for 10 minutes with oxygen plasma. This cleaning process was used to ensure 
uniformity and stability of the anti-stiction coating ((1H,1H,2H,2H-
perfluorooctyl)trichlorosilane, FOTS) which was deposited using molecular vapor deposition in 
order to prevent stiction between the silicon master and the polymer substrate during imprint.  
 
2.3 Substrate preparation 
 
A 3 µm film of undoped silicon oxide was vapor deposited onto clean silicon wafers to serve as a 
lower cladding material beneath the polymer waveguides and ring resonators. An 80:20 weight 
ratio blend of polystyrene (PS, Mw 13,502, Pressure Chemical Company, Pittsburgh, PA, USA) 
and polymethylmethacrylate (PMMA, Mw 15,000, Scientific Polymer Products, Ontario, NY, 
USA) was dissolved to 5% by weight in tetrahydrofuran. After filtering through a 0.22 µm nylon 
syringe filter, the polymer blend was spun on wafers for 30 seconds at 2000 rpm, followed by 
curing at 145 oC for five minutes to drive off residual solvent.  
 
2.4 Hot embossing 
 
Polymer waveguides and ring resonators were formed using nanoimprint lithography (Nanonex, 
Monmouth Junction, NJ, USA). Polymer substrates were brought into contact with silicon 
masters and degassed for 2 minutes during the chamber pump down. Substrates and masters 
were heated to 130 oC and pressurized to 120 psi to precondition the polymer, followed by 
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embossing at 140 oC and 500 psi for four minutes. In agreement with the previous literature, 
because of the aspect ratio between the waveguide structures and the thin polymer film, for many 
patterns higher pressure was needed than when imprinting other features [12-13]. Substrates 
were cleaved by marking the edge of the wafer onto which the polymer waveguides had been 
embossed using a diamond scribe, and carefully snapping the wafer along one of its crystal 
planes. Scanning electron microscopy revealed that this technique yielded smooth polymeric end 
facets, free of debris or roughness (see Figure 5b). On average this technique allowed us to yield 
approximately six working devices from a four inch wafer imprinted with a total of nine devices.  
 
2.5 Nanopore development 
 
Nanopores were introduced to the embossed optical structures by selectively developing out 
PMMA from the PMMA-PS composite devices. Ring resonators were covered in a droplet of 
dimethylsulfoxide (DMSO) for 2 hours, followed by rinsing in water and drying under filtered 
air. Because of the different solubility characteristics of PS and PMMA in DMSO only PMMA is 
removed this way leaving a porous polystyrene waveguide behind. Further, by localizing pores 
to only the resonators, and not the entire bus waveguide, transmission loses were significantly 
reduced. If pores were created by placing the devices in bulk DMSO solutions, pores developed 
much faster (2-10minutes), likely attributed to the better mass transport of the larger solvent. For 
longer times in DMSO the waveguide structures delaminate from the underlying silicon oxide. 
Additionally, development based on oxygen plasma was also investigated. By etching devices in 
oxygen plasma for 3 to 5 minutes PMMA can be removed from PS due to its higher reactivity 
with the oxygen species.  
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2.6 Surface analysis 
 
The morphology of nanoporous waveguides and resonators, as well as the integrity of embossed 
structures, were observed using scanning electron microscopy. A thin gold layer (<5 nm) was 
sputtered onto the waveguide structures prior to imaging and scanning electron microscopy was 
performed at energies between 1keV and 2 keV. Refractive indices of the polymers were 
determined on a Woollam Spectroscopic Ellipsometer scanning at angles of incidence ranging 
from 65o to 75o, varying wavelength from 3,000 to 10,000 Å. Film thickness was characterized 
using a FilMetrics Optical Film Measurement System (Filmetrics, Inc., San Diego, CA). Freeze 
fracture techniques in liquid nitrogen were also employed in order to determine the extent and 
depth of porosity. 
 
2.7 Microfluidic channels 
 
Microfluidic masters were fabricated using standard photolithography techniques and SU-8. Poly 
(dimethylsiloxane) (PDMS, Ellsworth Adhesives) molds were produced using soft lithography 
and aligned to our optical chips using a set of translational stages and a microscope. Holders for 
the device were laser cut out of Plexiglas and fit around the fluidic and optical layers as shown in 
Figure 4. This technique was used over traditional PDMS-glass oxygen plasma bonding because 
of the effect oxygen plasma has on our composite material. Holes punched through the PDMS 
layer were fit with small metal interconnects and tubes were attached allowing flow to be 
induced both with a syringe manually or with a syringe pump for regulated flow velocities. 
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Fig. 4. (a) An illustration of the experimental setup is shown. Polarized laser light is sent 
through a lensed fiber and coupled into the waveguide. The waveguide is offset by 3mm to 
prohibit scattered light from reaching the detector and outcoming light is refocused through an 
objective lens, put through a polarization filter, and then reaches a photodetector. (b) Optical 
and microfluidic devices are shown aligned and sandwiched between two Plexiglas device 
holders. The final assembly is screwed closed forming a tight seal around our microfluidic 
channels. Illustrations show the concentration of the light (c) and fluid (d) are localized to one 
small area over the resonator. (e) Shows a ring resonator imaged through the device and 
covered in aqueous solution. 
 
2.8 Optical excitation 
 
An Ando AQ4321D laser source (tunable between 1520 and 1620 nm) was used to couple light 
into polymeric waveguides as in previous work by our group [5]. Both the fiber and the chip are 
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mounted on 3-axis stages to ensure accurate alignment. The input and output facets of the 
waveguide are shifted by 3 mm to prevent detection of scattered light. Light that passes through 
the waveguide is collected and collimated, then passed through a polarizer to select only the TM 
mode, before reaching the photodetector, as shown in Figure 4a.  
 
2.9 Sensitivity measurements 
 
Resonator sensitivity was determined by immersing the waveguides in an aqueous cladding 
solution of varying amounts of glucose. Solution refractive indices were determined using a 
refractometer. Glucose concentrations were chosen in order to make sure resonant peak shift 
from one solution to another didn’t exceed the free spectral range of the devices in order to make 
sure peaks could be identified.  Specifically, five glucose solutions were chosen at approximately 
0, 5, 10, 15, and 20% to satisfy this requirement and because of availability.  Solutions were 
measured before each experiment to confirm their refractive index. 
 
3. Results and Discussion 
 
3.1 Lumerical FDTD simulations 
 
The results of our FDTD simulations indicate that polystyrene waveguides with dimensions 1 
µm in height by 2.5 µm in width support both one TE and one TM mode. Because of limitations 
from the fabrication techniques used we were only able to place our resonators within 250 to 400 
nm of the bus waveguide that evanescently coupled into them.  At this spacing, our simulations 
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determined that the racetrack resonators would achieve the highest energy storage with a 
coupling length of around 20 to 30 µm.  Comparing both scattering and bending losses we were 
able to determine that radii less than 20 µm had prohibitively high bending loses and that 
increases beyond radii of approximately 60 µm only seemed to increasing scattering losses.  This 
information was used to guide the fabrication of the resonators with the goal of obtaining 
reasonable Q factors.    
 
3.2 Porous resonator fabrication  
 
Resonators were place between 250 and 400 nm from our waveguide, the closest we were able to 
achieve with the i-line stepper we used. We produced racetrack resonators of sizes ranging from 
35 µm radii and 20 µm coupling lengths to 65 µm radii and 30 µm coupling lengths. By tuning 
parameters such as the ratio of the two polymers we were able to observe differences in resulting 
pore sizes. DMSO selectively removed PMMA from polystyrene without adversely affecting the 
polystyrene waveguide structure (Figure 5). Additionally, oxygen plasma etching created even 
more porous structures, but was difficult to isolate to only the ring region resulting in devices 
which scattered too much to optically excite and measure (Figure 6). Using a cleave and snap 
technique we were able to repeatedly generate smooth edges for light coupling with no 
deformation or debris. Porosity in solvent generated waveguides and resonators was 
approximately 9-10% of their surface area with pore diameters on the order of 60 to 120 nm and 
depths on the order of a few hundred nanometers. In general, there was little interconnectedness 
between pores in these waveguides. Because polystyrene has a contact angle less than 90˚ [24], 
we suspect the pores are wetting, and that aqueous solutions are capable of penetrating into the 
structure. 
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Fig. 5. (a) A scanning electron micrograph shows the complete ring resonator and its relative 
dimensions. (b) The end facets generated by our cleave and snap technique show how precisely 
the waveguides can be fractured.(c) An SEM illustrates the smallest feature size on our devices 
and show how the ring and bus waveguide smoothly come to within a few hundred nanometers of 
each other. Further, pores developed with DMSO are also shown here. 
 
Fig. 6. (a.) A scanning electron micrograph shows a ring resonator made porous using oxygen 
plasma. (b) An end facet which was freeze fractured shows pores running throughout the 
waveguide structure. (c) A racetrack resonator and waveguide are shown separated by 
approximately 300 nm, the smallest top down fabricated feature on the device. 
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3.3 Optical excitation and resonance measurements 
 
A typical spectrum from the resonators is shown in Figure 7. The cladding liquid here is water 
and approximately 1mW of laser power is coupled into the waveguide. After loses from coupling 
and scattering approximately 40-100 microwatts of power are collected at the detector. 
Depending on the exact fabrication of the resonator and any defects in it, we observed 
extinctions between 3 and 15dB at the resonant wavelength and Q-factors between 1000-3000. In 
general, we observed resonators with larger radii tended to outperform smaller ones, a factor we 
attributed to high bending losses due to the relatively small index difference between polystyrene 
and water. Resonance peaks were fit with Lorentzian functions in order to determine their 
location and full width half max. 
 
 
 
Fig. 7. A typical output spectrum of a porous resonator is shown. The free spectral range of the 
devices is approximately 2.8 nm, the quality factors range from 1000-3000, and on resonance 
wavelengths have extinctions between 3 and 15 dB. 
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3.4 Resonance shift as a function of porosity 
 
As DMSO is allowed to dissolve PMMA out from our waveguide we observe a blue shift in 
resonance corresponding to this loss of material. Using this type of measurement we can observe 
pores being added to our material simply through measurements of the optical resonance of the 
devices. Figure 8 shows measurements taken as a device was exposed to DMSO. After each 
exposure to DMSO the resonators were rinsed with water and dry air before the next 
measurement was taken. These rinsing and drying steps are important because the refractive 
index of DMSO is approximately 1.48, and when the porous resonator is covered with and filled 
by DMSO the resonant peaks red shift. As the DMSO evaporates the resonant peaks blue shift 
back and reach a final stable point once the DMSO is no longer present. 
 
Fig. 8. As the porosity of a ring resonator increases its resonance blue shifts. This change 
corresponds with decreasing mass and a shorter optical path and is a good indicator that pores 
are being generated. Measurements of resonance were taken with the resonator immersed in 
water at all four time points, and conditions were controlled so the only change was the addition 
of pores. 
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3.5 Effect of porosity on sensitivity 
 
Figure 9 shows resonances both before pores were added and after in a single device as well as 
SEMs of a nonporous device and after pores are added. A resonant peak is plotted at five 
different glucose concentrations for each resonator. Note that as the index of the cladding 
solution increases the resonant condition red-shifts, which corresponds with the longer optical 
path. This result agrees with Figure 8, where a blue-shift was observed due to a shortening of the 
optical path associated with the addition of pores. Due to increased interaction between the 
aqueous sample solution and the waveguide’s core energy the change in resonance is greater in 
the porous device. Additionally, Figure 10 compares the sensitivity of nonporous and porous 
resonators, showing a 42% increase in resonator sensitivity. Standard error is used to show inter 
device variability, which is significantly higher for the porous resonators compared to the 
nonporous, a characteristic we attribute to different porosity arising during fabrication. Both sets 
of data were fit with a linear regression running through the origin and sensitivities of 66.15 and 
94.05 were determined. The nonporous and porous resonator sensitivities have coefficient of 
determination (R2) values of .995 and .968, respectively, both indicating a good fit.  
 
4. Conclusions 
 
In this work we have shown how porous polymer waveguides can be fabricated using 
nanoimprint lithography and selective solvents. The porous structures created provide higher 
sensitivity than their nonporous counterparts and the modification can be performed in only one 
additional step using only a solvent. This modification can be made prior to functionalization and 
fits naturally into the creation of ring resonator biosensors. Additionally other changes could be 
made to further enhance the sensitivity of porous waveguides. One example is the use of wetting 
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agents that could allow bioanalytes to penetrate deeper into the porous waveguide structure and 
further increase sensitivity. A second example involves allowing bioanalyte solution to dissolve 
on the waveguide, concentrating the molecules of interest into the pores, where they would be 
capable of causing a greater change in sensitivity. One limitation in this work is the lack of 
quantitative biomolecular sensing studies. In future work we plan on functionalizing these 
porous waveguides for certain biomarkers and determining how their porous nature effects these 
detection reactions.   
 
Fig. 9. The resonance shift of nonporous (a) polymer resonators is compared to their (b) porous 
counterparts. Measurements are taken at five different concentrations of glucose between 0 and 
20 percent. As the refractive index of the cladding solution increases, a corresponding red shift 
is seen in the resonance condition of the rings. Because of increased bioanalyte electromagnetic 
energy interactions occurring in the porous waveguide the sensitivity of the device is 
significantly increased, and further shifts can be observed in (b) than (a). SEMs of a waveguide 
without pores (c) and of the waveguide after pores (d) are added are also shown.  
35 
 
The work presented here only shows a simple application of how two-polymer systems can 
be used to create interesting nanostructures for optics. Here the polymers are mixed in 
suspension and allowed to phase separate into random arrangements. In theory, it's possible to 
imagine that by creating diblock copolymers or other similar systems that two polymers could be 
caused to assemble into long-range ordered structures [25]. These nanostructures could not only 
allow for increased sensitivity in ring structures but could also potentially be used to create 
interesting optical materials, including self-assembled photonic crystals.  
 
Fig. 10. The sensitivity of a porous resonator is plotted against that of a nonporous resonator. 
An increase in over 40% sensitivity can be seen. The first data point appears at 0 corresponding 
to the resonator immersed in water.   
 
We have shown that by using simple polymer techniques the sensitivity of optical resonators can 
be increased by over 40%. While the sensitivity of polymer devices is generally lower than 
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traditional silicon devices these porous additions can provide polymer ring resonators an 
advantage. This increase in sensitivity combined with the simple fabrication and low cost 
associated with polymers can provide a distinct advantage to these devices and a simple way to 
make highly sensitive inexpensive biosensors. 
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CHAPTER 3 
 
MULTIPLEXED COLORIMETRIC DETECTION OF KAPOSI’S SARCOMA ASSOCIATED 
HERPESVIRUS AND BARTONELLA DNA USING GOLD AND SILVER 
NANOPARTICLES 
 
Kaposi’s sarcoma (KS) is an infectious cancer occurring most commonly in human 
immunodeficiency virus (HIV) positive patients and in endemic regions, such as Sub-Saharan 
Africa, where KS is among the top four most prevalent cancers. The cause of KS is the Kaposi’s 
sarcoma-associated herpesvirus (KSHV, also called HHV-8), an oncogenic herpesvirus that 
while routinely diagnosed in developed nations, provides challenges to developing world 
medical providers and point-of-care detection. A major challenge in the diagnosis of KS is the 
existence of a number of other diseases with similar clinical presentation and histopathological 
features, requiring the detection of KSHV in a biopsy sample. In this work we develop an answer 
to this challenge by creating a multiplexed one-pot detection system for KSHV DNA and DNA 
from a frequently confounding disease, bacillary angiomatosis. Gold and silver nanoparticle 
aggregation reactions are tuned for each target and a multi-color change system is developed 
capable of detecting both targets down to levels between 1 nM and 2 nM. The system developed 
here could later be integrated with microfluidic sample processing to create a final device 
capable of solving the two major challenges in point-of-care KS detection. 
 
Mancuso, M., Jiang, L., Cesarman, E., Erickson, D.  “Multiplexed Colorimetric Detection of Kaposi’s Sarcoma 
Associated Herpesvirus and Bartonella DNA using Gold and Silver Nanoparticles”  Nanoscale 5, 1678-1686 (2013)  
Reproduced with permission of the Royal Society of Chemistry  
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1. Introduction 
 
With the onset of the acquired immunodeficiency syndrome (AIDS) epidemic in the early 1980s, 
one of the first indicators of infected patients was the presence of red skin lesions, a symptom of 
a disease known as Kaposi’s sarcoma (KS) [1-4]. Before the discovery of the cause of AIDS, KS 
and other opportunistic infections were often the first signs, and biggest complications, for 
infected individuals. During this time significant research efforts were made to determine the 
cause of AIDS, and in 1983 HIV was discovered [5-6]. A little over ten years later the cause of 
KS was first connected to a second virus, Kaposi’s sarcoma-associated herpesvirus (KSHV), 
later given the alternative designation of human herpesvirus 8 (HHV-8) [7]. 
Today, KS is still the most prevalent cancer in untreated HIV-infected individuals. Initial 
studies showed that it affected 1 in 20 HIV-positive patients [8]. With the introduction of highly 
active anti-retroviral therapy (HAART), patients in the developed world have seen improvements 
in the management and treatment of KS, but it remains increased in incidence as compared to the 
pre-AIDS era in HIV-infected patients [9-10]. In regions of the developing world, such as Sub-
Saharan Africa, both HIV and KS are endemic, and KS is the fourth leading cancer in the region 
[11]. In some countries such as Uganda, KS is the number one cause of cancer in men [11-12]. 
The infectious cause of KS is now well known to be the oncogenic herpesvirus KSHV or 
HHV-8 [7, 13]. While the details of transmission are still being studied, it is most likely through 
saliva [14-16] and in some regions KSHV rapidly spreads beginning in childhood affecting large 
portions of the population, reaching seroprevalence of over 50% [11,17]. Like other 
herpesviruses, KSHV can establish a latent infection, and remains without causing any disease 
for the remaining life in most infected hosts, being necessary but not sufficient of KS 
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development. In locations where the seroprevalence of KSHV is this high, the clinically relevant 
test becomes determining if KSHV is present in a specific tumor, and not simply if it is present 
in a person’s blood.  
A second issue arises because of a number of other diseases have a similar presentation as 
Kaposi’s sarcoma, and are part of the differential diagnosis [18-20]. KS most often presents as a 
collection of red lesions, and when looked at on a typical hematoxylin and eosin (H&E) stained 
histology slide has a number of unique features, including vascular spaces and proliferation of 
spindle cells thought to be of lymphatic endothelial origin [13, 21]. However, while these 
features are characteristic of KS, a number of other diseases, including bacillary angiomatosis 
(BA) caused by Bartonella henselae or quintana, and pyogenic granuloma with no known 
infectious cause, can often have a similar clinical and histological appearance and represent a 
diagnostic challenge [18-19]. 
In developed clinical settings, skin biopsies are easily processed for histology using advanced 
tools including tissue processing systems and microtomes. KS diagnosis can then be made after 
an H&E staining through microscopic evaluation by a pathologist, and when the histological 
characteristics are uncertain, the presence of KSHV is determined to confirm the diagnosis either 
with immunohistochemistry specific for unique KSHV proteins or polymerase chain reaction 
(PCR) specific for unique KSHV DNA sequences. While the professional expertise and methods 
for sample preparation and diagnostic techniques are available in developed nations, they are 
scarce or nonexistent in many of the places where KS is most prevalent. If affordable point-of-
care diagnostics could be created that are capable of distinguishing KS from other similar 
conditions, better treatment could be provided. 
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Ultimately, two unique challenges present themselves in the creation of point-of-care 
diagnostics for Kaposi’s sarcoma in the developing world. The first is the requirement for the 
detection of KSHV in a biopsy sample without reliance on common laboratory technology. 
Extracting DNA from a skin biopsy sample using only simple, robust technology has thus far 
received little attention. The second challenge involves the presence of other diseases that can 
mimic KS, and thus the need for creating multiplexed detections that can distinguish one from 
the other. Further, these multiplexed detection systems need to be easily integrated to work with 
a small sample size, and in the presence of whatever surfactants and contamination is left over 
after DNA extraction. 
While diagnostics in the developing world in general pose a number of challenges, a large 
amount of work has been done addressing them. Recently an abundance of biosensors have been 
developing using mechanical [22-23], electrical [24], and optical [25], techniques to detect 
bioanalytes in minute quantities. Many of these devices combine microfluidics and other 
nanotechnologies in order to create tools which both operate at the length scale of the detection 
target and at a macroscopic scale which can be simply read-out. A number of them have even 
been applied in the developing world, where the additional constraints placed on devices by a 
lack of resources and trained personnel compound issues further [26-27]. Yet for all of the 
successes of these biosensors, a number of limitations still exist, including the need to pre-
process samples, the ability to work in a range of buffers (including those used to lyse cells), 
high sensitivity limits, and often a limited ability to detect multiple targets. 
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Fig. 1(a) and (b) Illustrate the aggregation of silver and gold nanoparticles in the presence of 
target DNA. As the nanoparticles aggregate their surface plasmons couple, the resonance 
condition changes, and their characteristic optical peaks red shift. (c) 600uL of gold 
nanoparticles, silver nanoparticles and a combination of both are shown, illustrating their 
optical properties. In the orange gold and silver solution each type of nanoparticle can be 
functionalized to react differently, allowing for either color change reaction to take place 
independently. 
Perhaps some of the most interesting recently developed diagnostic technologies are those 
which link the presence of a bioanalyte to changes in the localized surface plasmon resonance of 
metal nanostructures [28-30]. These devices are both highly sensitive and produce a convincing 
color-change that is discernible to the naked eye. To date techniques using nanoparticle based 
detection schemes have been applied to the recognition of oligonucleotides [31-32], proteins 
[33], metal ions [34], and other small molecules [35-36]. In the form of metal nanoparticles, 
localized surface plasmon resonance biosensors often rely on some target molecule to trigger 
particle aggregation. When nanoparticles aggregate as illustrated in Figures 1a and 1b, the 
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particles surface plasmons couple and their resonance condition changes. These colorimetric 
detection reactions were initially developed with sensitivities around 1nM to 10nM [31, 37]. 
Later work examined the limitations of these colorimetric nanoparticle aggregation detections, 
and determined the detection limit is ultimately a function of the relative concentration of 
nanoparticles to the concentration of DNA, and the size and optical cross section of the 
nanoparticles (among a few other factors) [28]. By using larger nanoparticles (~50nm) or a 
material with a higher optical cross section (i.e. silver) these colorimetric nanoparticle detection 
schemes have been optimized to reach sensitivities in the 50pM to 1nM range [28, 32, 38].  
Additionally, a number of other nanoparticle based detection schemes exist, which use the 
same recognition reaction, but a different sensing mechanism. Examples include scanometric 
based detection in which gold nanoparticles bind to a surface and are then made visible through 
the deposition of silver on their surface [26,39], bio-barcode based detection schemes where the 
DNA signal is amplified before a similar silver deposition [40], and simple spot-and-read tests 
where light from an illuminated glass slide is evanescently coupled into gold nanoparticles after 
aggregation [30]. It is difficult to produce a single low limit of detection because of the number 
of techniques and targets which exist, but nanoparticle based colorimetric detection schemes that 
integrate waveguiding glass slides have been shown to go to detection limits as low as 
approximately 300fM [30], and bio-barcode techniques have been shown to reach as low as sub-
attomolar detection limits [40-42]. 
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Table 1 Probe and Target Sequences for KSHV and BA 
Name Sequence 
TM (˚C) 
300mM NaCl 
KSHV Probe 1 AAAAAAAAAAAAAAAGCCAACGTCATTCCGCAGGAT 76.1 
KSHV Probe 2 AAAAAAAAAAAAAAAAGGCTGTGCGCTGTTGGTTCCT 78.7 
KSHV Target  ATCCTGCGGAATGACGTTGGCAGGAACCAACAGCGCACAGCCT 96.5 
Bartonella Probe 1 AAAAAAAAAAAAAAACCAATCGGTGGAGACGG 70.2 
Bartonella Probe 2 AAAAAAAAAAAAAAACGCTGACCAAGAGCAGGA 71.3 
Bartonella Target Sequence CCGTCTCCACCGATTGGTCCTGCTCTTGGTCAGCG 94.2 
 
Recently, smartphone based technologies have also been combined with a number of 
colorimetric technologies, allowing for point-of-care detection and quantification of target levels 
using pre-existing technology [43-44]. One pertinent example includes the use of a gold-on-
paper platform and a smartphone camera in order to detect DNA sequences from Mycobacterium 
tuberculosis, the cause of Tuberculosis [45]. 
 Here we present a solution to the differential diagnosis of KS and BA based on a 
colorimetric one-pot gold and silver nanoparticle system (Figure 1c). By combining these two 
oligonucleotide detection techniques in one solution we create a sysem that has two independent 
color change reactions depending on the DNA target present. We present both the visible color 
change associated with these detection reactions as well as the changes in the solutions optical 
spectrum and show the limit of detection of the system approaches single nanomolar 
concentrations. We demonstrate that our color change reactions have similar sensitivities to other 
aggregation reactions (~1nM), and that the two reactions do not interfere with each other. 
Because this multiplexed detection scheme can be carried out in one solution, it can later easily 
be integrated into a microfluidic device which solves the second challenge in KS detection, 
working with biopsy samples. Further, additional techniques, including illumination through an 
evanescently coupled glass slide, could later be utilized to further enhance our limit of detection. 
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2. Experimental Section 
 
2.1 Primer Design and Selection 
 
Oligonucleotide sequences were chosen for KSHV using BLAST Primer Design [46] to 
determine short DNA sequences (~20 BP) for DNA that codes for vCyclin, a KSHV protein 
known to express itself both during the latent and lytic viral phases [47]. The fact that vCyclin is 
expressed both latently and lytically could later be useful, because direct detection of extracted 
RNA could provide an additional template for amplification. Bacillary angiomatosis, a bacterial 
infection, can be caused by two different species, Bartonella quintana and henselae [48], and 
primers were designed to be specific to both agents. Briefly, the two bacteria genomes were 
compared to find conserved regions, a reference genome was created out of the conserved 
regions, and BLAST Primer Design was used to find oligonucleotides specific to these regions. 
A 15 base long polyadenine sequence was added to the 5’ end of the sequences, followed by an 
alkyl thiol group used to bind the oligonucleotides to gold particles. All oligonucleotides were 
ordered from Invitrogen (Grand Island, NY), and their sequence information can be found in 
Table 1. 
 
2.2 Gold and Silver Nanoparticle Functionalization 
 
Gold and silver particles with average diameters of 15 and 20 nm, respectively, were 
functionalized using thiol based chemistry using methods described by others [31-32, 37]. These 
sizes were chosen as a compromise between larger particles which generally provide higher 
48 
sensitivity [38], and smaller particles which are generally easier to make stable in salt solutions. 
Briefly, 50 µL of 100 µM oligonucleotides with 5’ alkyl thiol groups was added to 1 mL 
solutions of gold (3 nM) and silver (750 pM) nanoparticles in excess and allowed to react 
overnight. The solution was then brought to 10mM sodium phosphate and .01% sodium dodecyl 
sulfate (SDS), and again given 24 hr to react. This process was repeated, this time adding sodium 
chloride, resulting in final concentrations of 100 mM, 200 mM, and 300 mM, each time with 24 
hrs in between. These increasing molarity salt solutions are used to screen electrostatic 
interactions between DNA strands, ultimately allowing for a higher density layer to be formed on 
the surface of the nanoparticles. After the final incubation period, solutions were spun down and 
resuspended in .01% SDS three times to remove excess oligonucleotides, and finally brought to 
10 mM Sodium Phosphate and 300 mM Sodium chloride.  
 
2.3 Melting Temperature Analysis 
 
In previous literature Storhoff et al. [37] and Thompson et al. [32] have shown how gold and 
silver nanoparticle-based aggregation can have specificity high enough to determine single 
nucleotide mismatches between targets. A perfect and one nucleotide mismatched target have 
different melting temperatures, and by measuring what temperature the nanoparticles 
disassociate one can distinguish between the two. A similar disassociation temperature is 
determined here for a correct target for both nanoparticle systems, and further detection reactions 
are performed at a temperature just below this threshold to insure incorrect targets don’t cause 
any aggregation. KSHV and Bartonella DNA (10 nM) sequences were added to solutions of 
conjugated gold and silver nanoparticles respectively, and the solutions were allowed 4 hr to 
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aggregate. Then, the solutions were heated in 5 degree increments from 45 °C to 95 °C to 
determine at what temperature the nanoparticles disassociated.  
 
2.4 KSHV and BA Detection and Sensitivity Measurements 
 
Solutions of gold and silver nanoparticles were mixed to yield a final concentration of 1.5 nM 
gold nanoparticles and 325 pM silver nanoparticles. Due to silver’s higher absorption cross 
section, a lower concentration was used. Target and Control DNA were added at concentrations 
of 5 nM and solutions were kept 2 hrs at 65 °C to react before their absorbance measurements 
were recorded. Similarly, experiments were conducted to measure the limit of detection of the 
system. Different concentrations of DNA from 10 pM to 1 uM were added to 40 µL of both 
silver and gold independently to measure the sensitivity of each channel. Solutions were given 2 
hr at 65 °C to react, and their near UV and visible spectrums were collected. 
 
 2.5 Materials and Instrumentation 
 
Spectrophotometric measurements were taken using a Spectramax plus 384 (Molecular Devices, 
Sunnyvale, CA) in the Nanobiotechnology Center at Cornell University. SEMs were taken on a 
Zeiss Ultra (Oberkochen, Germany) in the Cornell Center for Nanofabrication. Gold 
nanoparticles were purchased from Nanopartz (Loveland, CO). All other reagents were 
purchased from Sigma-Aldrich (St. Louis, MO).  
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Fig. 2 (a) Silver and (b) Gold Nanoparticles functionalized using thiolated oligonucleotides. 
After conjugation, both spectrums red shifted by approximately 1-3 nm, as similarly reported in 
previous literature. The change in total absorption is mostly due to incompletely collection of the 
nanoparticles after conjugation. Silver and gold particles after conjugation are shown in the 
inset images respectively.   
 
3. Results and Discussion 
 
3.1 Nanoparticle-Oligonucleotide Conjugation 
 
The attachment of oligonucleotides to gold and silver nanoparticles yielded homogenous stable 
solutions of nanoparticle conjugates the same color as the original solution. As in previous work 
by Storhoff et al. and Thompson et al., a small change of roughly 1 to 3 nm in nanoparticle 
resonance was observed in accordance with the nanoparticle conjugations, as shown in Figure 2 
[32, 37].  
51 
 
Fig. 3 After allowing solutions of the nanoparticles to aggregate the temperature that they 
disassociated at was determined. For both the KS and BA a sharp increase in absorbance was 
seen at their melting temperatures, approximately 80 and 75 degrees, respectively. 
 
Decreases in absorbance were also observed due to incomplete collection of nanoparticles 
during excess oligonucleotide removal. The final gold nanoparticle solutions were stable for 
greater than 1 month at room temperature, while the silver particles were stable for 
approximately two weeks. This difference in stability is likely attributed to the different reaction 
constants between gold and thiol and silver and thiol.  
 
3.2 Melting Temperature Analysis  
 
The results of the melting temperature analysis indicated that the KSHV functionalized 
nanoparticles disassociated between 75 °C and 80 °C, and the Bartonella functionalized 
nanoparticles between 70 °C and 75 °C, as shown in Figure 3. These results line up well with the 
expected melting temperatures of the oligonucleotide probes, which can be found in Table 1. 
Further, the lower melting temperature of the Bartonella probes agrees well with the length of the 
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probes being 5 nucleotides shorter. These temperature results were used to choose 65 °C as the 
temperature that the detection and sensitivity experiments were conducted at to prevent 
nonspecific aggregation. 
 
Fig. 4 (a) A solution of conjugated gold and silver nanoparticles. (b) Upon introduction of KSHV 
DNA the gold particles aggregate and the solution turns darker orange. (c) Upon introduction of 
BA DNA the silver nanoparticles aggregate, and the solution becomes bright pink. (d) An optical 
spectrum illustrates the change in the nanoparticles resonance as they aggregate. All DNA 
solutions added in these experiments were 5nM. 
 
3.3 Multiplexed KSHV and BA DNA Detection Experiments 
 
In experiments using both KSHV functionalized gold and Bartonella functionalized silver 
nanoparticles (Figure 4a), upon successful aggregation and detection of one target, the 
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multiplexed solution displayed a color more similar to the non-aggregated solution. For example, 
when Bartonella target DNA (BA DNA) was introduced to the solution the silver nanoparticles 
aggregated and the solution turned to a pink color, more dependent on the surface plasmon 
characteristics of the unaggregated gold particles (Figure 4b). When KS DNA was introduced the 
gold nanoparticles aggregated and the solution changed to a murky yellow-orange color, more 
dependent on the silver nanoparticles (Figure 4c). Spectrophotometric analysis also revealed that 
only the wavelength resonant peak of the nanoparticle aggregate was affected by the detection of 
a single target (Figure 4d). A small change in the absorption at the non-target-corresponding 
resonant wavelength is observed due to a change in the corresponding resonant peak’s tail, but 
the resonant peaks wavelength did not change. Further, Scanning Electron Micrographs reveal 
that upon introduction of a target, an aggregation reaction does indeed occur (Figure 5). For the 
gold nanoparticles a color change could be visually observed as early as 30 minutes to 1 hour 
after addition of DNA and for the silver nanoparticles as early as one hour after the addition of 
target. Measuring the absorbance of the solutions we were able to see changes as soon as 10 to 
20 minutes after the addition of target. 
When gold nanoparticles and silver nanoparticles were mixed and stored together the silver 
nanoparticles would gradually and nonspecifically aggregate over the course of two to three 
days, even in the presence of no target. Presumably this aggregation was caused by a reaction 
between the thiol groups of the Bartonella probe DNA attached to the silver nanoparticles 
reacting with the gold nanoparticles because of thiol and gold’s greater reaction constant. 
However, over the time span of our reactions, no change was observed in the silver 
nanoparticles, allowing for multiplexed detection in one solution. 
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3.4 Sensitivity Experiments 
 
Detection reactions were carried out at various target DNA concentrations to determine the limit 
of detection of the system. Our results indicate that the limit of detection of the gold 
nanoparticles is approximately 2nM, and for the silver nanoparticles is approximately 1nM 
(Figure 6). The limit of detection of the silver nanoparticles is likely higher because their higher 
absorption cross section allows for a lower concentration of nanoparticles that can aggregate in 
the presence of less DNA. These results line up well with previous nanoparticle-based 
colorimetric detection, which shows limits of detection for gold around approximately 1nM, and 
for silver around approximately 100pM [32, 37].  
 
 
 
Fig. 5 Scanning electron micrographs of unaggregated oligonucleotide conjugated silver and 
gold nanoparticles on a silicon wafer. After the addition of target DNA the silver and gold 
nanoparticles form aggregates. 
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While these limits of detection are high for the detection of unamplified DNA, there are a 
number of techniques that we could later implement to allow our multiplexed system to directly 
detect extracted DNA. One example previously mentioned involves evanescently coupling light 
from illuminated glass slides into the nanoparticles to excite them as opposed to a broadband 
source. Storhoff et al. report a limit of detection of 300fM, demonstrating how this simple light 
source can provide an almost 1000 fold increase in sensitivity using the same nanoparticles [30]. 
Ultimately, they use their system to detect unamplified genomic DNA. A second technique 
which could be used to directly detect KSHVs presence involves detecting mRNA already 
transcribed from the genomic DNA. As explained previously vCyclin, is expressed both latently 
and lytically, and orders of magnitude more copies could be available for detection. 
 
4. Conclusions 
 
Here we have demonstrated a multiplexed colorimetric one-solution method of detecting KSHV 
and Bartonella DNA. We have shown that gold and silver nanoparticle conjugates can be used in 
one solution for colorimetric detection, and that both color change reactions can be seen 
independently of each other. Our results indicate that this sort of technique can be used to 
differentiate DNA from these two similarly presenting diseases with speeds on the same order of 
PCR based techniques (minutes to hours), and faster than immunohistochemistry based ones 
(hours to days). 
In this work we demonstrate such a multiplexed detection using two targets, but it is possible 
to imagine that by using nanoparticles of other shapes, sizes, and materials, a multiplexed 
solution could be created capable of many colorimetric detection reactions for different targets. 
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In addition to nanospheres like those used in this work, nano- rods [49], prisms [50-51], 
bipyramids [52-53], and a number of other geometries [54-56] exist with different SPR 
wavelengths. Depending on how much overlap is allowed between SPR peaks of different 
nanoparticles, anywhere from a handful to dozens of detections could be carried out within the 
width of the visible spectrum. 
While improvements are still needed in order to detect unamplified DNA, the techniques here 
could be easily integrated into more complex microfluidic devices, forming diagnostics capable 
of solving both major challenges in KS diagnosis: disease differentiation and starting with a solid 
sample. While in this work our samples are most illustrative of a biopsy sample after significant 
processing, in future work the system could be built to accept biopsy samples directly. A number 
of possible solutions exist for increasing the sensitivity of colorimetric nanoparticle-based 
detection, including the previously mentioned examples of detecting amplified RNA targets, 
such as vCyclin RNA, or using evanescent coupling into the particles to measure only scattered 
light. Additionally, lower limit detection could be possible by using nanoparticles at 
concentrations that are not visible to bind to target DNA, and then concentrating any resulting 
aggregates using a microfluidic device.  
Another interesting case where multiplexed colorimetric detection based on metal 
nanoparticles could be applied is the detection of HIV and syphilis in the developing world, a 
problem recently tackled by Chin et al [26]. In this case, both diseases are treatable, but in 
pregnant women can become fatal to their children. Chin et al. develop a microfluidic ELISA 
chip to solve the problem and demonstrate amazing results with clinical samples. Here a 
multiplexed colorimetric solution could provide an easier readout in a similar device that could 
provide the patient with more confidence in the result. 
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Since therapeutics capable of controlling HIV, and thus in many cases KSHV, have been 
created the incidence rates of KS in the United States has decreased. However, in other areas of 
the world KSHV is still a major cause of cancer. Better diagnostics, potentially built utilizing the 
system described above, could be useful in diagnosing and allowing for subsequent treatment. 
The capability of multiplexed detections in one solution is particularly interesting in the case of 
differentiating between Kaposi’s sarcoma and bacillary angiomatosis, as well as pyogenic 
granuloma by exclusion, where added difficulties besides multiplexing will arise from having to 
extract a bioanalyte from solid samples. In this case because of the limited sample size single 
solution multiplexed detection has an important advantage.  
 
Fig. 6 (a) Sensitivity of both gold and silver nanoparticles conjugates. A color change was 
observed for silver solutions at 1nM DNA, and for gold nanoparticles at 2nM. (b) and (c) show 
the absorbance of the two systems between 1nM and 10nM, in the systems transition region. 
Note that this difference in sensitivity is likely because the silver nanoparticles are kept at a 
lower concentration while still providing a similar optical signal, a factor of the higher optical 
cross section of silver. 
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Here we have demonstrated work towards creating such a detection reaction that could later 
be integrated into a diagnostic device. We have shown that it is capable of detecting multiple 
targets, and that its limit of detection falls in line with similar work, and could be enhanced 
further using other known techniques. In future work we hope to integrate the reaction with 
biopsy-based detection, and solve both challenges involved in KS diagnosis. 
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CHAPTER 4 
 
DETECTION OF KAPOSI’S SARCOMA ASSOCIATED HERPES VIRUS NUCLEIV ACIDS 
USING A SMARTPHONE ACCESSORY  
 
Kaposi’s sarcoma (KS) is an infectious cancer occurring in immune-compromised patients, 
caused by Kaposi’s sarcoma associated herpes virus (KSHV). Our vision is to simplify the 
process of KS diagnosis through the creation of a smartphone based point-of-care system capable 
of yielding an actionable diagnostic readout starting from a raw biopsy sample. In this work we 
develop the sensing mechanism for the overall system, a smartphone accessory capable of 
detecting KSHV nucleic acids. The accessory reads out microfluidic chips filled with a 
colorimetric nanoparticle assay targeted at KSHV. We calculate that our final device can read 
out gold nanoparticle solutions with an accuracy of .05 OD, and we demonstrate that it can detect 
DNA sequences from KSHV down to 1 nM. We believe that through integration with our 
previously developed components, a smartphone based system like the one studied here can 
provide accurate detection information, as well as a simple platform for field based clinical 
diagnosis and research. 
 
 
 
 
 Mancuso, M., Cesarman, E., Erickson, D.  “Detection of Kaposi’s Sarcoma Associated Herpes Virus Nucleic 
Acids Using a Smartphone Accessory,” (Submitted) 
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 1. Introduction 
 
Kaposi’s sarcoma (KS) is an opportunistic infectious cancer that first became widely known 
during the acquired immunodeficiency syndrome (AIDS) epidemic of the 1980s [1-4]. During 
this time period, the appearance of KS symptoms, red lesions on the skin, became signs that an 
individual was infected with human immunodeficiency virus (HIV), and KS itself became 
known as an AIDS-defining illness. As the battle against AIDS waged on, the introduction of 
highly active anti-retroviral therapy (HAART) helped reduce KS incidence [5]. Years later, 
however, HIV infected individuals still contract KS at a higher occurrence than when compared 
to the pre-AIDS era [6]. Considering its prevalence in HIV infected individuals, KS if often 
found in regions with high levels of AIDS. KS is the fourth leading cancer in sub-Saharan 
Africa, and in some countries, such as Uganda, is the most prevalent cancer in men [7-8].  
The root cause of KS is the Kaposi’s sarcoma herpesvirus (KSHV), also called human 
herpesvirus 8 (HHV-8) [9-10]. While the virus is often asymptomatic in healthy individuals, a 
number of populations, including those immune-compromised by HIV, are vulnerable to its 
symptoms and aggressive disease. The virus is commonly believed to be transmitted through 
saliva [11], and in some regions rapidly spreads beginning in childhood affecting large portions 
of the population, reaching seroprevalence of over 50% [8,12]. Like other herpesviruses, KSHV 
can establish a latent infection, and remains without causing any disease for life in most infected 
hosts, being necessary but not sufficient for KS development. Considering this, one of the 
biggest challenges in diagnosing KS involves having to detect KSHV in a biopsy sample and not 
simply a blood draw. 
 
If typical hematoxylin and eosin (H&E) staining is applied to a KS biopsy section a number 
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of unique features can be observed, including many and large vascular spaces as well as high 
numbers of spindle cells thought to be of lymphatic endothelial origin [13-14]. However, due to 
the existence of similarly presenting diseases, such as bacillary angiomatosis (BA), identification 
of these features is frequently not sufficient for diagnosis of KS [15]. In modern hospitals, this is 
solved through immunohistochemistry staining for protein markers of KSHV, or through 
application of PCR for KSHV sequences.   
However, neither of these techniques are readily adaptable for point of care field use 
situations in the developing world, where KS is most prevalent.   Our long term goal is to create 
a biopsy diagnostic that can be used in this scenario, enabling the entire process from sample 
collection to diagnostic readout. In previous work, we began addressing this challenge to create 
point of care biopsy diagnostics for KS by creating a colorimetric nanoparticle based detection 
system, similar to the works of Thompson et al. [16] and Storhoff et al. [17-18], that was capable 
of detecting KSHV DNA [19]. However, one of the shortcomings of the system is that without 
laboratory technology, the test really can only be read out as a binary assay, and thus the amount 
of information it could provide was limited. 
Recently, a number of mobile health technologies have been developed that seek to solve this 
problem of quantifiable point of care diagnosis. These devices take advantage of all of the 
computational, connectivity, display, and other functionality already built into a smartphone and 
use it to create better point-of-care devices. Further, they capitalize on the ubiquitous nature of 
smartphones, and the near universal ability to use them. 
A number of papers have been published in the literature showing how smartphones can be 
used as field-portable microscopes [20-23], as colorimetric test strip readers [24-26], as rapid 
diagnostic test readers [27], for allergen detection [28], and even for label free detection [29]. 
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These devices have proven extremely useful for portable imaging and in cases where diagnostic 
tests are commercially available. They advance the state of the art towards biochemical testing, 
yet are currently limited to only a few tests. 
 
 
Fig. 1 (a) An image of the entire microfluidic smartphone system is shown including the Android 
application, the smartphone accessory, and a microfluidic chip being inserted.  (b) The inside of 
the microfluidic chip is shown, with the light source and optical sensor out of position to include 
them in the image (normally they are across the width of the microfluidic chip).  (c) An example 
microfluidic chip is shown illustrating the 1cm optical path the light travels through and the 
magnetic latch to help align the chip with the reader. 
 
Mobile health technologies could be even further enhanced through their integration with 
additional microfluidic and lab-on-a-chip technologies. While many microfluidic devices exist in 
the literature [30-38], their penetration into commercial markets has been limited, as Chin et al. 
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well document in a recent review [39]. One of the challenges many of these devices face is the 
requirement for an expensive chip “reader” that contains electronics, optics, computation, 
display, and other functionality necessary for interrogating a test. If tests like these could 
ultimately be connected to smartphones, which already contain much of the required electronics, 
they could more easily penetrate into consumer markets. 
In this work we create a smartphone accessory capable of measuring KSHV DNA. We 
develop a working accessory, a smartphone app, and disposable microfluidic chips, and show 
how we can detect KSHV DNA in a PDMS microfluidic chip. Overall, we show that we can 
measure nanoparticle solutions down to nanomolar concentrations, and detect KSHV DNA at 
similar levels.  We hope that in the future the detection technology developed here will be 
integrated with other components, including syringe biopsy technology and solar thermal DNA 
amplification [40], to fully enable point-of-care biopsy based KS detection. 
 
2. Experimental 
 
Two smartphone accessories were created capable of reading out nanoparticle aggregation assays 
in standard laboratory cuvettes and 1cm long microfluidic channels. The cuvette based reader 
was used as a proof-of-concept device and to determine how to create the optical system.  The 
rest of the work focuses on the microfluidic system, composed of a smartphone accessory, 
disposable microfluidic chips, and a smartphone app. The accessory connects to Android devices 
and is controlled by an Android app to obtain absorbance readouts across microfluidic chips. 
Figure 1 illustrates the system and its three components. The system was tested by reading out a 
gold nanoparticle aggregation assay developed for detecting KSHV DNA. 
2.1 Software Development 
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The smartphone app was developed in Eclipse (Eclipse Foundation, Ottawa, Canada) for the 
Android platform (Google, Mountain View, CA). The code was written in java and used the 
Android SDK tools (Google, Mountain View, CA). The software was written to communicate 
with a USB accessory in accessory mode (host mode for the cuvette prototype), allowing the 
Android device to provide power for the smartphone accessory. When triggered via a button 
press in the app interface (see Figure 2), a signal is sent to the smartphone accessory requesting a 
read-out of the current absorbance. The app then receives this read-out, displays it to the user, 
and saves it in temporary memory. As results are collected, they can also be automatically tagged 
with user information, time stamps, and locations to provide relevance to the results. Figure 2c 
illustrates the process flow of the software. 
 
 Fig. 2 (a) and (b) show screenshots of the Android application including where measurement 
output is recorded, how measurements are triggered, and additional functionality for emailing 
and saving data.  (c) A flow chart illustrates the high level operation of the software running on 
both the Android phone and the Arduino microcontroller when a measurement is taken. 
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In addition to the app’s core functionality, utilities were added to email results to other 
experimenters or medical professionals, to store results as text files on a connected Google Drive 
account, or even to create keyhole mark-up language files (KML files) that can be opened in 
Google Maps, Google Earth, or many other geographic applications (Figure 2b). Using these 
functions together, a simple database of test read-outs from numerous devices can be created, 
similar to that detailed in other work27.  Eventually, records from similar accessories could be 
uploaded directly to patient’s electronic medical records.  
 
2.2 Optical Readout Circuitry 
 
The accessory contains an LED light source at the peak wavelength of the nanoparticles 
resonance (520nm) and a photocell, placed across a 1cm gap where a sample is placed (Figure 
2a).  The photocell is connected via a pull-down resistor and measurements of the voltage drop 
across the photocell are made to determine luminosity.  This results in an inversely proportional 
relationship between the output of the voltage measurement and the amount of light illuminating 
the photocell described by: 
 
ܸ = ௜ܸ௡ ோು೓೚೟೚೎೐೗೗ோು೓೚೟೚೎೐೗೗ାோುೠ೗೗ష೏೚ೢ೙   (1) 
 
Where V is the voltage drop across the photocell, Vin is the power supplied to the resistor-
photocell system, and RPhotocell and RPull-down are the resistance of the photocell and pull-
down resistor respectively.  If we also consider that the log of the resistance of a photocell is 
proportional to the log of the intensity of incident light given by: 
 logܴூ =  −݉ log ܫ +  ݇   (2) 
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Where RI is the resistance for a given intensity, I, and m and k are constants relating to the 
specific photocell, and that absorbance through a medium varies according to the Beer-Lambert 
law given by: 
ܶ = ூ
ூబ
= 10ିఌ௟௖    (3) 
 
Where T is transmitted light, I is transmitted Intensity, I0 is initial intensity, ε is molar 
absorptivity, l is the optical path length, and c is concentration then we can see that our voltage 
output is proposal to a sigmoid function of concentration: 
 
ܸ ∝ ௜ܸ௡
 ଵ଴షഄ೗೎
ଵ଴షഄ೗೎ାோುೠ೗೗ష೏೚ೢ೙
   (4) 
 
By choosing the pull-down resistors resistance to make sure that typical concentrations fall in the 
middle of this range, a linear fit can then be used to describe the relation between voltage and 
optical density.   
 
2.3 Cuvette Based Reader Proof of Concept and Circuitry 
 
An accessory capable of reading out absorbance measurements across a cuvette was created to 
first demonstrate a smartphone’s ability to measure nanoparticle absorbance and to test our 
optical component.  This early prototype was based on an IOIO microcontroller board (Sparkfun, 
Boulder, CO) which enabled simple communication with the smartphone, but required external 
power and use of the USB Host interface.  The microcontroller was connected to the LED and 
pull-down resistor and communicated measurement results with the smartphone. 
All of the controlling electronics and measurement circuitry are house in a casing was printed 
using an Objet Connex500 3D printer (Stratasys, Eden Prairie, MN).  This early prototype was 
battery powered, and connected via a USB cable to the Android phone. 
73 
2.4 Microfluidic Smartphone Accessory Design 
 
The final microfluidic smartphone accessory can communicate with any modern Android 
smartphone or tablet, via power and communication through the devices µUSB port. The device 
consists of an 8MHz Pro Micro Arduino (Sparkfun, Boulder, CO), which controls the same type 
of LED and photodetector as used in the earlier prototype. The microcontroller connects to a 
male µUSB connector in order to draw power from and communicate with the smartphone. The 
entire system is enclosed in a black plastic case, printed similarly to the previous cuvette device, 
to block out ambient light. 
 
Fig. 3 (a) The cuvette based accessory is shown, along with (b) the spectrum of five gold 
nanoparticle solutions used to calibrate the accessory.  (c) Shows the results of these initial 
experiments illustrating the changing accessory readout as a function of optical density.  The 
sensitivity of the device was .5V/OD (R2 = .99). 
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The case holds the LED directly across from the photodiode, both behind approximately 
.5mm apertures. When a microfluidic chip is inserted, the path between the two components is 
filled with a 1cm path length fluidic channel full of a nanoparticle solution. A ceramic magnetic 
is also connected to the end of the accessory, useful for holding the microfluidic chip in 
alignment.  The device can be seen in Figure 1b. 
 
2.5 Microfluidic Chip Fabrication 
 
Microfluidic devices were made of PDMS and glass and plasma-bonded together, as done 
extensively in the literature41-42. Briefly, a mold was made from laser cut polyacrylic using a 
VersaLASER laser cutter (Hobart Lasers, Kent, UK). This technique was chosen over the SU-8 
or other microfabrication techniques because larger channels were desired for alignment, but 
similar microstructures could be easily integrated. The mold was then cast in PDMS, put under 
vacuum to removed trapped air bubbles, and baked overnight.  
The resulting PDMS cast was cut from the mold, paying careful attention to leave 1mm of 
PDMS at the end of the sensing channel, enabling a thin interface for optical measurements 
along the width of the chip. Holes were punched at the inlet and outlet using and the PDMS 
channels and a microscope slide were then plasma treated in a Harrick Plasma Cleaner (Harrick 
Plasma, Ithaca, NY) for 30s. The treated surfaces were pressed together, and allowed an hour to 
bond. Small magnetic strips were then attached to the front of the microfluidic chips, helping 
with alignment once placed in the accessory. Fluidic actuation was provided using a syringe.  A 
sample chip is shown in Figure 1c. 
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2.6 Gold Nanoparticle Assay  
 
Short DNA sequences used as probes for KHSV DNA were designed previously using BLAST 
Primer Design43. Briefly, oligonucleotides specific to KSHV DNA that codes for vCyclin, were 
chosen. Gold nanoparticles were conjugated with oligonucleotides with 5’ alkyl thiol groups, as 
in previous work. The nanoparticles had an average diameter of 15nm, a compromise between 
the higher sensitivity of larger particles, and the easier to work with nature and stability of 
smaller particles. 100 µL of 100 µM KSHV probes were added per 1mL of 3nM nanoparticle 
solution, and allowed to react overnight. Concentrated solutions of sodium phosphate and 
sodium dodecyl sulphate (SDS) were then added in order to bring the solution to 10mM and 
.01% concentrations, respectively, before another overnight period to reaction. Next, three 
additions of sodium chloride were added, resulting in concentration of 100mM, 200mM, and 
300mM, each with 24 hours in between. This process worked to maximize the number of bound 
DNAs per particle, making more stable gold nanoparticle conjugates. After this, the resulting 
solution was spun down and resuspended in .01% SDS three times to remove unbound 
oligonucleotides. Sodium phosphate and Sodium chloride were then re-added to the final 
solution, resulting in final concentrations of 10mM Sodium Phosphate and 300mM Sodium 
chloride.  Particles were then stable and usable for over a month. 
 
2.7 Nanoparticle Sensitivity Characterization 
 
Gold nanoparticle solutions of different concentrations were created in order to calibrate the 
device. 1 OD 15nm nanoparticles were diluted to concentrations of .8 OD, .6 OD, .4 OD, .2 OD, 
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and 0 OD. The absorbance of these solutions was measured using a SpectraMAX photometer 
(Molecular Devices, Sunnyvale, CA).  These solutions were then placed in the cuvette based 
accessory, and read-out using an Android smartphone.  Results were collected and plotted as a 
function of optical density.  A best fit line was also calculated and plotted. 
Similarly, these solutions were inserted into the microfluidic chip via syringe, and measured 
in order to determine the devices read-out at these absorbance levels. By mapping these results to 
the spectrometer’s output, we created a calibration curve for the smartphone accessory. These 
curves were then used in further experiments to determine the optical density of solutions after 
the addition of KSHV DNA.  Calibration curves were individually calculated for separate 
microfluidic chips. Measurements across chips was also collected, and plotted as a function of 
optical density, to show a measure of inter-chip repeatability. 
 
2.8 Quantitative KSHV DNA Experiments 
 
Gold nanoparticle conjugates were mixed with different concentrations of the target KSHV DNA 
sequence, ranging from 100pM, to 1µM. After 24 hours, the solutions were inserted into the 
smartphone accessory. The solutions were then measured by the smartphone, and the results 
were saved to the connected Google Drive for analysis.  While solutions were given 24 hours to 
react in this work, we have carried out similar experiments at smaller volumes in as little as two 
hours in previous work [19], and there is literature precedent for faster times [18].  The main 
constraint here was due to diffusion in larger sample sizes prepared for multiple experiments.  
Resulting solutions were then measured using both our laboratory spectrometer and our 
microfluidic chip based system.  Sensitivity results were calculated, and comparisons were made 
between the laboratory read-outs and our point of care readings. 
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Fig. 4 (a) intra- and (b) inter- chip calibration and accuracy are shown for the microfluidic 
system.  The data in (a) was then used as calibration data for the detection experiments. Within 
the single chip shown in (a) the sensitivity of the system was .77V/OD (R2 = .98) and across 
three chips the sensitivity was .82V/OD (R2 = .98), showing a high level of reproducibility. 
 
3. Results and Discussion 
 
3.1 Nanoparticle Sensitivity Results 
 
Our cuvette reader and the results of our initial experiments using this system can be seen in 
Figure 3, along with the spectrum of the standard solutions used for calibration experiments.  
The change in voltage as a function of different optical density solutions can be seen.  Error bars 
are shown, but difficult to see, as this initial system produced very tightly reproducible 
measurements, with standard deviations on the order of 2mV.  The large volume of gold 
nanoparticle solution used insured that from the perspective of the sensor, the optical path was 
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always completely filled.  The sensitivity of our reader, how much our voltage output changes 
with changing optical density, was roughly .5V/OD (R2 = .99).  Considering this sensitivity, our 
error, Vin = 3.3V, and that our reading from the sensor is 10bit (1024 values), our sensor can 
read out optical densities to an accuracy of roughly .01 of an OD.  This takes into account that 
the accessory has roughly 150 values in a 1OD range with our given sensitivity, and that our 
sensitivity is roughly on this scale (+/- 1 value).  While this represents a best case value, even 
significantly less sensitive readings could be useful in point-of-care settings. 
Figure 4 shows the resulting calibration data when comparing absorbance in our smartphone 
accessory to a commercial spectrometer. Both single and multiple chip measurements are shown, 
illustrating the intra- and inter- chip variations. As we can see from the results, our current 
prototype allows for highly repeatable measurements in a single chip and good measurements 
across chips. We believe that the additional variation between chips was the effect of channel 
alignment with the optical path, as well as uneven interfaces where the light enters and exits the 
chip. Together, these variations could account for unequal optical path lengths in the solution, as 
well as unequal scattering at the interfaces of the chip. We believe that both of these problems 
can be solved as we develop better techniques for repeatedly creating microfluidic chips that are 
measured along their width. 
When considering the sensitivity of a single microfluidic chip, we actually calculate a higher 
sensitivity of .77V/OD (R2 = .98), a result of a smaller aperture and a different pull-down 
resistor. Considering again the accuracy of our device, we now have over 230 distinct voltage 
readings in our 1 OD range.  However, because of alignment issues inserting a single chip 
repeatedly, the standard deviations of these measurements were approximately 9mV, larger than 
the voltage difference between values.  Considering this, our microfluidic reader is accurate to 
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roughly .05 OD increments, though again this could be improved with better alignment, a more 
sensitivity detector, or more accurate read-outs of the photocell we use here.   
While the sensitivity calculated across three chips was roughly the same (.82V/OD, R2 = .98) 
as to the single chip case above, the standard deviation increased to roughly 15mV, a result of 
alignment differences between chips.   
 
3.2 KSHV Detection and Quantification 
 
The results of our quantitative KSHV DNA detection experiments are summarized in Figure 5. 
Figure 5a shows the sensitivity of our assay, read out by both a spectrometer and our 
microfluidic smartphone accessory. Figure 5b compares the readouts of these two devices, 
showing a strong agreement between their results (best fit slope = .92, R2 = .96).  Figure 5c 
shows the solutions tested at each point and how much KSHV DNA was added to each. 
Solutions with higher DNA concentrations were able to more completely react, and to do so 
more quickly, resulting in higher changes in absorbance at 520nm. Here our measurements use 
the calibration data for each of three microfluidic chips to calculate an optical density for these 
samples.     
Our results indicate that with the current non-optimized system we can detect KSHV DNA 
down to nanomolar concentrations.  However, other advances in nanoparticle based detection 
have been used to create much more sensitive systems than here (where a smaller amount of 
analyte results in a greater changed in OD), and if integrated with our smartphone accessory 
would likely yield more sensitive results. 
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4. Conclusions 
 
Kaposi’s sarcoma and other infectious diseases represent very real risks to human health both in 
the developing and developed world.  The first step in treating these diseases is the identification 
of individuals affected, and to a lesser extent, how the disease is spreading.  In this work we 
show how a smartphone based system can be cheaply and easily created to help solve both of 
these challenges.  We demonstrate how the smartphone accessory we create can read out 
different concentrations of gold nanoparticles, as well as gold nanoparticle aggregation reactions 
that can be used to test for a number of different diseases. 
Fig. 5 (a) shows the optical density of the gold nanoparticle solution after the addition of 7 
different concentrations of KSHV DNA.  For concentration starting at 500pM and up to 1µM 
both the smartphone accessory and the spectrometer were able to detect changes in the color of 
the nanoparticle solution. (b) A plot of the optical density as determined by both the 
spectrometer and the smartphone accessory is shown, in comparison to a line representing 
parity.  A best fit calculates an agreement of .92 between the two sets of measurements (R2 = 
.96). (c) Images of the seven different solutions are shown. 
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In this work, we demonstrate our system using DNA from KSHV.  However, the same 
smartphone reader could be used with a number of other colorimetric reactions for things like 
Methicillin-resistant Staphylococcus aureus (MRSA) [44] and vitamin D levels [45].  Further, 
the same reader could be used in realms outside of healthcare, to detect things like heavy metal 
ions in water [46-49]. 
Unlike many devices in the literature that use the smartphone’s camera, here we show how a 
simple standalone system can be built.  While ultimately the inclusion of a separate optical 
detector can increase the cost and complexity of such a device, it has numerous advantages too. 
First, such a device isn’t affected by changes in cameras between devices, allowing for more 
repeatable measurements, without any computational correction.  Second, such a device could 
ultimately incorporate more sensitive detectors, creating diagnostics better suited for pathologies 
with low limits of detection.  Lastly, one of the major challenges facing new diagnostics is often 
getting regulatory approval to launch such a device.  While a camera based system is simple to 
implement, it is difficult to prove manufacturing control and repeatability when the sensor isn’t 
directly coming from the diagnostic vendor, a problem that is circumvented through inclusion of 
a separate detector.  
 
5. Acknowledgements 
 
This work was partially supported by NIH-NIBIB under grant EB016803.  M. Mancuso would 
like to acknowledge a National Science Foundation Graduate Research Fellowship under Grant 
No. DGE-0707428. This work was performed in part at the Cornell NanoScale Facility, a 
member of the National Nanotechnology Infrastructure Network, which is supported by the 
82 
National Science Foundation (Grant ECS-0335765) and at the Nanobiotechnology Center 
(NBTC), an STC Program of the National Science Foundation under Agreement no. ECS-
9876771. 
 
6. References 
 
1. Pitchenik, A.E., et al., Opportunistic infections and Kaposi's sarcoma among Haitians: 
evidence of a new acquired immunodeficiency state. Ann Intern Med, 1983. 98(3): p. 
277-84. 
2. CDC, Update on Kaposi's sarcoma and opportunistic infections in previously healthy 
persons--United States. MMWR Morb Mortal Wkly Rep, 1982. 31(22): p. 294, 300-1. 
3. Hymes, K.B., et al., Kaposi's sarcoma in homosexual men-a report of eight cases. Lancet, 
1981. 2(8247): p. 598-600. 
4. Friedman-Kien, A.E., Disseminated Kaposi's sarcoma syndrome in young homosexual men. J 
Am Acad Dermatol, 1981. 5(4): p. 468-71. 
5. Eltom, M.A., et al., Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in 
the United States from 1973 through 1998. J Natl Cancer Inst, 2002. 94(16): p. 1204-10. 
6. Nguyen, H.Q., et al., Persistent Kaposi sarcoma in the era of highly active antiretroviral 
therapy: characterizing the predictors of clinical response. AIDS, 2008. 22(8): p. 937-45. 
7. Jemal, A., et al., Global cancer statistics. CA: A Cancer Journal for Clinicians, 2011. 61(2): 
p. 69-90. 
83 
8. Ferlay J, et al. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 
[Internet]. GLOBOCAN 2008 v1.2  2010  [cited 2011 11/15/2011]; Available from: 
http://globocan.iarc.fr]. 
9. Cesarman, E., et al., Kaposi's Sarcoma-associated Herpesvirus-like DNA sequences in AIDS-
related body cavity-based lymphomas. N Eng J Med, 1995. 332: p. 1186-1191. 
10. Chang, Y., et al., Identification of herpesvirus-like DNA sequences in AIDS-associated 
Kaposi's sarcoma. Science, 1994. 266: p. 1865-1869. 
11. Ablashi, D.V., et al., Spectrum of Kaposi's sarcoma-associated herpesvirus, or human 
herpesvirus 8, diseases. Clin Microbiol Rev, 2002. 15(3): p. 439-64. 
12. He, J., et al., Seroprevalence of human herpesvirus 8 among Zambian women of 
childbearing age without Kaposi's sarcoma (KS) and mother-child pairs with KS. J Infect 
Dis, 1998. 178(6): p. 1787-90. 
13. Tappero, J.W., et al., Kaposi's sarcoma: Epidemiology, pathogenesis, histology, clinical 
spectrum, staging criteria and therapy. Journal of the American Academy of 
Dermatology, 1993. 28(3): p. 371-395. 
14. Mesri, E.A., E. Cesarman, and C. Boshoff, Kaposi's sarcoma and its associated 
herpesvirus. Nat Rev Cancer, 2010. 10(10): p. 707-719. 
15. Tappero, J.W. and J.E. Koehler, Bacillary Angiomatosis or Kaposi's Sarcoma? New 
England Journal of Medicine, 1997. 337(26): p. 1888-1888. 
16. Thompson, D.G., et al., Ultrasensitive DNA Detection Using Oligonucleotide−Silver 
Nanoparticle Conjugates. Analytical Chemistry, 2008. 80(8): p. 2805-2810. 
17. Rosi, N.L. and C.A. Mirkin, Nanostructures in Biodiagnostics. Chemical Reviews, 2005. 
105(4): p. 1547-1562. 
84 
18. Storhoff, J.J., et al., One-Pot Colorimetric Differentiation of Polynucleotides with Single 
Base Imperfections Using Gold Nanoparticle Probes. Journal of the American Chemical 
Society, 1998. 120(9): p. 1959-1964. 
19. Mancuso, M., et al., Multiplexed Colorimetric Detection of Kaposi's Sarcoma Associated 
Herpesvirus and Bartonella DNA using Gold and Silver Nanoparticles. Nanoscale, 2013. 
20. Greenbaum, A., et al., Wide-field computational color imaging using pixel super-resolved 
on-chip microscopy. Opt. Express, 2013. 21(10): p. 12469-12483. 
21. Greenbaum, A., U. Sikora, and A. Ozcan, Field-portable wide-field microscopy of dense 
samples using multi-height pixel super-resolution based lensfree imaging. Lab on a Chip, 
2012. 12(7). 
22. Isikman, S.O., et al., Field-portable lensfree tomographic microscope. Lab on a Chip, 
2011. 11(13): p. 2222-2230. 
23. Lee, M., O. Yaglidere, and A. Ozcan, Field-portable reflection and transmission 
microscopy based on lensless holography. Biomed. Opt. Express, 2011. 2(9): p. 2721-
2730. 
24. Veigas, B., et al., Gold on paper-paper platform for Au-nanoprobe TB detection. Lab 
Chip, 2012. 12(22): p. 4802-8. 
25. Oncescu, V., D. O'Dell, and D. Erickson, Smartphone based health accessory for 
colorimetric detection of biomarkers in sweat and saliva. Lab on a Chip, 2013. 
26. Shen, L., J.A. Hagen, and I. Papautsky, Point-of-care colorimetric detection with a 
smartphone. Lab on a Chip, 2012. 12(21): p. 4240-4243. 
27. Mudanyali, O., et al., Integrated rapid-diagnostic-test reader platform on a cellphone. 
Lab on a Chip, 2012. 12(15): p. 2678-2686. 
85 
28. Coskun, A.F., et al., A personalized food allergen testing platform on a cellphone. Lab on 
a Chip, 2013. 13(4): p. 636-640. 
29. Gallegos, D., et al., Label-free biodetection using a smartphone. Lab on a Chip, 2013. 
13(11): p. 2124-2132. 
30. Sharma, H., et al., Unconventional Low-Cost Fabrication and Patterning Techniques for 
Point of Care Diagnostics. Annals of Biomedical Engineering, 2011. 39(4): p. 1313-
1327. 
31. Nguyen, D., et al., Better shrinkage than Shrinky-Dinks. Lab Chip, 2010. 10(12): p. 1623-
6. 
32. Lutz, B., et al., Dissolvable fluidic time delays for programming multi-step assays in 
instrument-free paper diagnostics. Lab on a Chip, 2013. 
33. Fu, E., et al., Transport in two-dimensional paper networks. Microfluidics and 
Nanofluidics, 2011. 10(1): p. 29-35. 
34. Lutz, B.R., et al., Two-dimensional paper networks: programmable fluidic disconnects 
for multi-step processes in shaped paper. Lab on a Chip, 2011. 11(24): p. 4274-4278. 
35. Fu, E., et al., Chemical signal amplification in two-dimensional paper networks. Sensors 
and Actuators B: Chemical, 2010. 149(1): p. 325-328. 
36. Nie, Z., et al., Electrochemical sensing in paper-based microfluidic devices. Lab on a 
Chip, 2010. 10(4): p. 477-483. 
37. Nie, Z., et al., Integration of paper-based microfluidic devices with commercial 
electrochemical readers. Lab on a Chip, 2010. 10(22): p. 3163-3169. 
38. Martinez, A.W., et al., Diagnostics for the Developing World: Microfluidic Paper-Based 
Analytical Devices. Analytical Chemistry, 2009. 82(1): p. 3-10. 
86 
39. Chin, C.D., V. Linder, and S.K. Sia, Commercialization of microfluidic point-of-care 
diagnostic devices. Lab on a Chip, 2012. 12(12): p. 2118-2134. 
40. Jiang, L., et al., Solar thermal polymerase chain reaction for smartphone-assisted 
molecular diagnostics. Submitted, 2013. 
41. Whitesides, G.M., The origins and the future of microfluidics. Nature, 2006. 442(7101): 
p. 368-373. 
42. McDonald, J.C. and G.M. Whitesides, Poly(dimethylsiloxane) as a Material for 
Fabricating Microfluidic Devices. Accounts of Chemical Research, 2002. 35(7): p. 491-
499. 
43. Altschul, S.F., et al., Gapped BLAST and PSI-BLAST: a new generation of protein 
database search programs. Nucleic Acids Res, 1997. 25(17): p. 3389-402. 
44. Storhoff, J.J., et al., Homogeneous detection of unamplified genomic DNA sequences 
based on colorimetric scatter of gold nanoparticle probes. Nat Biotech, 2004. 22(7): p. 
883-887. 
45. Farrell, C.-J.L., et al., State-of-the-Art Vitamin D Assays: A Comparison of Automated 
Immunoassays with Liquid Chromatography–Tandem Mass Spectrometry Methods. 
Clinical Chemistry, 2012. 58(3): p. 531-542. 
46. Hung, Y.-L., et al., Colorimetric Detection of Heavy Metal Ions Using Label-Free Gold 
Nanoparticles and Alkanethiols. The Journal of Physical Chemistry C, 2010. 114(39): p. 
16329-16334. 
47. Knecht, M. and M. Sethi, Bio-inspired colorimetric detection of Hg2+ and Pb2+ heavy 
metal ions using Au nanoparticles. Analytical and Bioanalytical Chemistry, 2009. 394(1): 
p. 33-46. 
87 
48. Darbha, G.K., et al., Selective Detection of Mercury (II) Ion Using Nonlinear Optical 
Properties of Gold Nanoparticles. Journal of the American Chemical Society, 2008. 
130(25): p. 8038-8043. 
49. Lee, J.-S., M.S. Han, and C.A. Mirkin, Colorimetric Detection of Mercuric Ion (Hg2+) in 
Aqueous Media using DNA-Functionalized Gold Nanoparticles. Angewandte Chemie 
International Edition, 2007. 46(22): p. 4093-4096. 
88 
 
CHAPTER 5 
 
CONCLUSIONS 
 
Over the course of my work I made significant improvements to polymer waveguide resonator 
biosensors and mobile health point of care diagnostics.  In the following sections I outline my 
major accomplishments and challenges by project, as well as provide some information on future 
directions of the work. 
 
5.1 Summary of Accomplishments 
 
5.1.1 Nanoporous Polymer Ring Resonators for Biosensing 
 
In this chapter, I presented novel work on how to create and use porous waveguide biosensors.  
These innovative devices used new materials to enable both simpler fabrication, and more 
importantly, structures that greatly increased the interaction between stored optical energy in the 
resonator and biomolecules in solution.  The overall results showed a 40% increase in device 
sensitivity when compared to nonporous devices.  Some of the key research accomplishments in 
this work included: 
 
 Creation of porous polymer ring resonators using nanoimprint lithography, with top-
down fabricated features down to 300nm, and chemically etched pores on the order of 
50nm. 
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 Development of freeze fracture and electron microscopy techniques to observe and 
characterize the porous resonators 
 Optimization of multiple chemistries to create pores small enough to avoid excessive 
light scattering while large enough to increase biomolecular interaction 
 Development of clamp-on microfluidics which enabled biomolecule-waveguide 
interaction at small volumes while not mechanically or chemically destroying the delicate 
waveguide structures. 
 Optical testing of the novel devices, demonstrating a 40% increase in overall sensitivity 
 
5.1.2 Multiplexed Colorimetric Detection of Kaposi’s Sarcoma Associated Herpesvirus and 
Bartonella DNA using Gold and Silver Nanoparticles 
 
In Chapter 3, I demonstrated the development of a multiplexed colorimetric detection system for 
the differential diagnosis of two different pathogens.  Gold and silver nanoparticle aggregation 
reactions were developed in such a way that the two reactions remained independent, with little 
cross-talk. The novel system was one of the first to use nanoparticles and colorimetric 
multiplexing, and was an instrumental stepping stone towards creating field portable diagnostics 
for Kaposi’s Sarcoma.  Some of the research highlights from this chapter included: 
 
 Determination and development of suitable chemistries for creating color changing 
detection reactions sensitive enough to measure nanomolar concentrations of DNA. 
 Optimization of bioconjugation chemistries in order to create independent reactions with 
little to no molecular cross-talk 
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 Demonstration of high specificity and nanomolar sensitivity of both reactions. 
 Detection of KSHV and Bartonella DNA using the final system 
 
5.1.3 Detection of Kaposi’s Sarcoma Herpes Virus DNA Using a Mobile Health Smartphone 
Accessory 
 
In Chapter 4, work was presented on quantitative diagnosis of Kaposi’s sarcoma DNA using a 
smartphone accessory.  In this work we demonstrated for the first time how colorimetric gold 
nanoparticle aggregation reactions could be read out using a smartphone accessory.  This work 
was one of the first to create an optical smartphone accessory capable of reading out a 
biodetection reaction and unique from similar previous works in its exclusion of the smartphone 
camera. We demonstrated the ability to detect KSHV DNA down to nanomolar levels in 
microfluidic chips.  Some of our key breakthroughs included: 
 
 Development of a smartphone powered optical detection accessory that could read out 
colorimetric reactions 
 Calibrations tests showing the sensitivity and resolution of our prototype 
 Sensing experiments showing smartphone detection of KSHV DNA down to nanomolar 
concentrations 
 Additional features including geo-tagging and map-creation that can enable new 
epidemiologic studies. 
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5.2 Future Directions 
 
5.2.1 Nanoporous Polymer Ring Resonators for Biosensing 
 
At the conclusion of our work on porous polymer ring resonators, we had developed a polymer 
system capable of achieving higher sensitivities through unique materials.  Due to the fabrication 
and materials selected, we could have continued developing on our devices to create flexible, 
wearable optical biosensors.  An illustration of what such a sensor could have looked like is 
shown in Figure 1.  Sensors like these ultimately could be used by the chronically ill to measure 
disease status, by early response workers to measure potential threats, and by soldiers to detect 
weaponized pathogens. While ultimately I chose to pursue a different direction with my 
dissertation work, polymer waveguide biosensors is still a very active area of research, and our 
work[1] has already been cited numerous times as of this writing. 
 
Fig. 1 A diagram illustrates what our porous polymer waveguides could one day ultimately be 
built into.  Combining flexible polymer optical layers with similar fluidics and electronics could 
one day be used to create form-fitting biosensor wearables. 
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5.2.2 Multiplexed Colorimetric Detection of Kaposi’s Sarcoma Associated Herpesvirus and 
Bartonella DNA using Gold and Silver Nanoparticles 
 
In Chapter 3, the development of a colorimetric detection scheme for Kaposi’s sarcoma 
associated herpesvirus was described.  This work was performed at the start of a new 
collaboration with Professor Ethel Cesarman, and has gone on to result in a number of new 
projects, including the following work in my thesis. Overall, the aim of our collaboration is to 
create point of care diagnostics for KS that complete the whole process from sample collection, 
to entry into a patient’s electronic medical record.  Figure 2 outlines the concept behind this idea. 
 
Fig. 2  The concept behind our broader point of care KS diagnostic is shown.  A sampel is 
collected using a biopsy syringe, amplified with solar-thermal PCR and fed into the color change 
reaction developed in Chapter 3, and ultimately read out using a smartphone based system as in 
Chapter 4. 
 
The first part of this work, the development of a method to collect a biopsy and extract DNA 
from it, has been tackled by the Cesarman lab.  There, they are developing a method where the 
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biopsy samples can be lysed using only minimal chemicals and external infrastructure in a way 
that produces DNA ready for amplification in step 2.  I’ve also made small contributions in this 
area, providing early vision for this part of the project, and creating prototypes of what a system 
capable of doing steps 1 and 2 might look like.  This early prototype is shown in Figure 3, and 
consists if a biopsy needle and a syringe attached in such a way that a sterile sample can be 
collected and fed right into a microfluidic chip. 
 
 
Fig. 3 (A) Shows a prototype lab on a syringe device, demonstrating how a sample can be 
collected using a syringe, and ultimately injected into a microfluidic chip, where a colorimetric 
detection reaction can occur.  (B) Illustrates two ways in inserting a biopsy sample followed by 
(C) showing the addition of necessary reagents.   (D) Shows the final microfluidic chip, and a 
detection location where a color change can be observed. 
 
In addition to the colorimetric detection already described in Chapter 3, the second part 
of this overall system also has the ability to amplify DNA using solar-thermal polymerase chain 
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reaction.  This system was ultimately designed and published on by my colleague, Li Jiang, who 
I collaborated closely with over the duration of the project[2].  I contributed to this project 
providing some of the earliest engineering designs for the system (shown in Figure 4 along with 
Jiang’s final system) and help with the biochemical aspects of the project.    While the results of 
this work are ultimately those of Li Jiang, for the sake of the project as a whole it’s worth noting 
that the final PCR system can work on samples with as little as 100 copies per µL. 
 
 
Fig. 4  (top) The concept for our solar thermal PCR is shown.  A smartphone us used to control 
the device and read out temperatures, while most of the power required for the amplification 
comes from the sun.  The microfluidic chip used with the system is shown on the right.  (bottom) 
The final working system is shown used in the field, along with a close-up of the microfluidic 
chip [2]. 
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The next steps for the first two parts of this system involve field testing in sub-Saharan 
Africa, scheduled for February 2014.  My colleagues will be taking parts of the system to two 
different field locations to see if preliminary results can be obtained using our device. Following 
these tests, the goal is to conduct larger scale clinical trials, and see if our technology can one 
day ultimately be used in the field. 
 
5.2.3 Detection of Kaposi’s Sarcoma Herpes Virus DNA Using a Mobile Health Smartphone 
Accessory 
 
 
 
 
Fig. 5 A map file is shown with multiple readouts of different KSHV levels.  Ultimately, 
epidemiologic maps can be created that could be used to better manage and triage disease on a 
population level. 
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In Chapter 4 of this dissertation, results were presented on smartphone based readout of our 
KSHV assay.  Ultimately this system will be used as the final part of our overall KSHV field 
diagnostic, as described above.  In addition to the results presented in the chapter, one additional 
advantage smartphones provide is their ability to add extra information to diagnostics tests.  One 
example, geo-tagging, can be used to create non-identifying epidemiologic information as tests 
are recorded.  Figure 5 shows an example KML file created using our smartphone accessory and 
app, mapping recordings of KSHV levels to different locations.  Other examples include adding 
information through the smartphone interface collected via physical examination, or uploaded 
through other devices.  In its current form, the future of this work will ultimately be its 
integration into the complete system. 
 More exciting to me than the initial work alone, during the course of my research on 
smartphone based biochemical diagnosis, colleagues and I began developing a whole collection 
of different uses for such technology.  This original work acted as a springboard for a number of 
other research projects colleagues of mine lead, including smartphone accessories to measure 
sweat pH [3], cholesterol levels [4], and vitamin D levels[5].  The more we looked, the more it 
became clear that mobile health technologies are going to be much more than simply part of one 
diagnostic.  Figure 6 illustrates one of these new systems a colleague, Seoho Lee, developed to 
detect vitamin D levels using a smartphone [5].  Going forward, my work on smartphone 
diagnostics will hopefully fuel many other researchers, leading to all sorts of applications 
ranging from simple tests for things like ovulation, to home use cancer diagnostics.  Attached at 
the end of this document is an appendix of some tests which could be modified to work on a 
smartphone. 
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Fig. 6 A smartphone accessory for vitamin D is shown, based on using the smartphone camera 
to detect a colorimetric reaction [5]. 
 
5.4 Concluding Remarks 
 
As described in Chapter 1, I believe one day mobile health accessories will be used as the first 
step in healthcare, reducing the burden on doctors and providing an unprecedented level of 
distributed healthcare.  As outlined in my work, there exists numerous opportunities to create and 
commercialize advanced diagnostics for home-use.  I hope that my contributions to the field, in 
summary the adoption of gold nanoparticle diagnostics to smartphone accessories, will be 
expanded upon by others, and one day inspire a new generation of portable diagnostics. 
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